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ABSTRACT
A Smartphone Intervention to Reduce Hospital Readmission Rates in Adult Patients who
Have Heart Failure
Jami L. Crisman, BSN, RN
Heart failure (HF) is the leading cause of 30-day hospital readmission, with up to 23.5% of Medicare
beneficiaries requiring subsequent admission within 30 days post hospital discharge (CMS, 2020a).
Mobile-health applications (MHA), such as smartphone applications, have emerged as cost-effective
methods to safely manage chronic disease in the outpatient setting (Inglis et al., 2015). The purpose
of this evidence-based practice (EBP) project was to evaluate the impact of a MHA on HF-related
30-day readmission rates. The Iowa Model Revised guided the implementation of the project in a
rural, for-profit hospital in Northwest Indiana. An extensive literature search was conducted, and a
MHA project plan was implemented. Adult inpatients (N = 18) who were admitted with a diagnosis of
HF exacerbation were identified through a comprehensive chart review process. A prospective
between group comparison design allowed for assessment of thirty-day and 8-week readmission
rates for each group. Readmission rate data were analyzed using a one-way multivariate analysis of
variance (MANOVA). No significant difference in readmission rates were appreciated between
groups (Llambda(2,4) = .804, p > 0.05). To further evaluate if any association existed between the
use of the MHA and readmission rates, epidemiologic measures of association were evaluated (OR
= 0.156, 95% CI 0.013 - 1.828, p > 0.05, ARR = 0.33; NNT = 3). No statistically significant results
were identified. Despite non-significant results of the primary outcomes, clinical significance can be
appreciated. Statistically significant differences were noted in pre- (M = 3.81, sd = .654) and postintervention (M = 2.57, sd = .672) selfcare behavior scale scores (t = 4.06, p = 0.005). Findings from
this project may be used to further evaluate the use, long-term benefits, and financial implications of
MHA interventions on HF-related readmissions.
Keywords: HF, 30-day readmission, MHA, smartphone
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CHAPTER 1
INTRODUCTION
Background
Current State
Heart failure is the leading cause of 30-day hospital readmission for United
States’ (US) Medicare beneficiaries aged 65 years and older, with an estimated 21.9% (Centers
for Medicare and Medicaid Services [CMS], 2020a) to 23.5% (Dharmarajan et al., 2017) of
patients requiring hospital readmission within 30 days of primary hospitalization. The cyclical,
progressive nature of heart failure symptomatology predisposes patients to an increased risk for
decompensation and secondary complications, requiring readmission within 30 days of hospital
discharge (Fitch, Engel, & Lau, 2017). In addition to the physiologic burden of the disease, heart
failure is one of the most financially burdensome chronic conditions currently impacting adults
within the US (Benjamin et al., 2019). The costs associated with hospital readmissions are
exorbitant, with each occurrence ranging in fees from $11,840 (Fitch et al., 2017) to $14,631
(Kilgore, Patel, Keilhorn, Maya, & Sharma, 2017). These estimates contribute to the continually
increasing, multi-billion-dollar national annual expenditure for heart failure management. Among
Medicare expenditures, hospitalizations for heart failure management generate the highest
number, cost, and rate of 30-day readmissions (Fitch et al., 2017). Fifty-three percent of
Medicare all-cause readmissions are due to heart failure, with costs totaling 2.3% of the overall
annual Medicare expenditure (Fitch et al., 2017). The American Heart Association (AHA) has
predicted that the United States’ total medical costs related to heart failure will increase from
$31 billion in 2012 to $70 billion in 2030 (Heidenreich et al., 2013). Secondary to the increasing
incidence, prevalence, and cost related to management of heart failure, Healthy People 2030
now includes a goal (HDS-09) to reduce overall hospitalization for patients who have heart
failure (HHS, ODPHP, 2020).
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In 2012, after many years of unsuccessfully combatting insurmountable healthcare
utilization costs, the US government passed the Affordable Care Act (ACA), a program
designed to improve access to healthcare services for all US citizens, and to decrease Medicare
expenditure (CMS, 2020b). Another initiative of the ACA is to reduce healthcare costs related to
potentially preventable expenditures, such as hospital readmissions (CMS, 2020c). The Hospital
Readmissions Reduction Program (HRRP) detailed within the ACA, was created to track
unplanned readmissions for acute and chronic conditions such as: (a) acute myocardial
infarction, (b) chronic obstructive pulmonary disease, (c) heart failure, (d) pneumonia, (e)
coronary artery bypass graft surgery, and (f) elective primary total hip arthroplasty and/or total
knee arthroplasty (CMS, 2020c). The purpose of this program is to link Medicare reimbursement
that health care organizations receive, to quality-of-care measures (CMS, 2020b). Thirty-day
readmission rates are used to measure performance of healthcare organizations. Those with
disease-specific readmission rates that surpass national, state, and local rates are penalized a
portion of Medicare reimbursement funds (CMS, 2020b; Kilgore et al., 2017).
Data from the Literature Supporting Need for the Project
Due to the enforced financial incentive, healthcare organizations have trialed multiple
interventions, both pharmacological and nonpharmacological, to decrease the overall
readmission rates and to maximize Medicare reimbursement. Guidelines for pharmacological
management of heart failure are widely used in practice (American Heart Association [AHA],
2017); however, such guidelines do not exist for nonpharmacological management. Many
nonpharmacological interventions, such as early outpatient follow-up after discharge (AHA,
2017; Hollenburg et al., 2019), nurse-initiated telephone follow-up (Hollenburg et al., 2019),
nurse home visits (Takeda et al., 2019; Van Spall et al., 2017), and multidisciplinary care teams
(Gandhi et al., 2017; Oyanguren et al., 2016; Van Spall et al., 2017; Takeda et al., 2019) have
been trialed and have either proven to be too expensive to maintain or ineffective at decreasing
overall readmission rates.
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More recently, secondary to advancing technology and the current focus on telehealth
platforms, telemonitoring interventions that incorporate daily transmission of vital signs and
symptomatology have emerged as interventions that have the potential to effectively decrease
heart failure-related 30-day readmission rates (Gorodeski et al., 2020; Kitsiou, Paré, & Jaana,
2015; Kotb, Cameron, Hsieh, & Wells, 2015; Lin, Yuan, Huang, & Zhang, 2017; Dadosky et al.,
2018; Hamilton, Mills, Birch, & Thompson, 2018; Frederix et al., 2019; Rosen, McCall, &
Primack, 2017; Aronow & Shamliyan, 2018; Clark, 2018). The definition of telehealth is as
follows: “the use of medical information exchanged from one site to another via electronic
communications to improve a patient’s clinical health status” (American Telemedicine
Association, 2020).
Evidence suggests that intervention(s) implemented at the earliest sign of symptom
exacerbation is the greatest combatant of decompensation and subsequent hospitalization
(AHA, 2017). Therefore, in order to reduce heart failure related 30-day readmission rates and
associated healthcare costs, it is imperative to identify an effective heart failure management
intervention that can be implemented in the outpatient setting to assist in daily self-care
measures and to identify symptoms of exacerbation early, preventing the need for inpatient
management.
Defining Heart Failure, 30-day Readmission Rates, and Associated Terms
Heart Failure
Heart failure is a chronic, progressive, and incurable disease in which the heart muscle
insufficiently supplies blood and oxygen to the remainder of the body (Benjamin et al., 2019).
Decreased oxygen delivery leads to multiorgan dysfunction and results in a multimorbidity state
with symptoms that include: (a) dyspnea, (b) edema, (c) fatigue, (d) tachycardia, (f) ischemia,
and (g) blood pressure fluctuation (Benjamin et al., 2019). Early in the disease process, the
body will attempt to compensate for the decrease in cardiac output caused by the failing heart
by increasing the rate of contraction and stretching cardiac muscle to create a stronger
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contraction that eventually leads to cardiac remodeling with dilated muscle mass (Plank, 2019).
Ultimately, these compensatory measures fail leading to decreased perfusion of vital organs
and a host of secondary complications (Plank, 2019). A brief description of the types of heart
failure and classification systems follow; however, these topics are largely beyond the scope
and purpose of this project.
Types of heart failure. There are two main types of heart failure recognized by the
AHA: left-sided heart failure, and right-sided heart failure, (Plank, 2019). The left side of the
heart is largely responsible for pumping freshly oxygenated blood to the rest of the body. There
are two subcategories of left-sided heart failure. Heart failure with reduced ejection fraction
(HFrEF), or systolic failure, occurs when the left side of the heart contracts insufficiently (Plank,
2019). As a result, cardiac output, or the amount of blood ejected from the left ventricle, is
decreased, and tissue and organ perfusion throughout the body is reduced, leading to
pulmonary congestion (Plank, 2019). Heart failure with preserved ejection fraction (HFpEF), or
diastolic failure, occurs when the left ventricle stiffens and cannot sufficiently relax to allow
normal filling of blood into the ventricle (Plank, 2019). This also leads to insufficient pumping of
blood from the ventricle because there is a smaller amount present at the initiation of the
contraction (Plank, 2019). Right-sided heart failure usually develops as a result of left-sided
heart failure or chronic lung conditions (Plank, 2019). The main objective of the right side of the
heart is to transfer unoxygenated blood out of the heart and into the lungs to be reoxygenated
before it is returned to the left side of the heart to be ejected to the rest of the body (Plank,
2019). After compensating for a failing left ventricle, or excess pressure from the pulmonary
system, the excess fluid pressure is transferred in a retrograde fashion from the pulmonary
system and stresses the muscles within the right side of the heart, ultimately leading to failure
(Plank, 2019). As a result, blood stagnates within the body’s vascular system, leading to jugular
venous distention, edema, and ascites. All patients who have heart failure are subject to the
same daily maintenance requirements and are at risk for exacerbation and subsequent
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hospitalization regardless of the type of disease present. Therefore, all patients who have heart
failure should have a method of intervention that promotes self-care measures and aids in the
event of exacerbation.
Heart Failure Classification. There are multiple heart failure classification systems that
are used for different purposes. In 2001, the AHA developed a simplified heart failure
classification system. Based on heart failure risk factors, symptomatology, and structural
changes within the heart, patients are categorized into four progressive, independent stages: A,
B, C, or D (Hunt et al., 2001). This classification system does not allow for retrograde movement
between classes. Patients falling into category A have risk factors for developing heart failure,
such as hypertension, diabetes mellitus, obesity, hyperlipidemia, sedentary lifestyle, poor diet,
and/or cigarette use without overt heart disease or symptoms (Hunt et al., 2001). Category B
heart failure occurs when there are structural changes identifiable within the heart, but the
patient does not experience symptoms of decompensated cardiac output (Hunt et al., 2001).
The patient progresses to category C when structural changes are identifiable within the heart
and symptoms of decompensation are present (Hunt et al., 2001). Lastly, category D heart
failure classification is appropriate when the patient experiences advanced disease with overt
symptomatology requiring continuous aggressive medical management (Hunt et al., 2001).
Population Affected. Heart failure is the endpoint of many chronic disease processes
and the accumulation of damage inflicted by lifestyle risk factors (Hunt et al., 2001). Due to the
body’s ability to compensate for a failing heart, cumulative effects may not be observable for
quite some time, making advanced age the biggest risk factor for heart failure diagnosis
(Heidenreich et al., 2013). An estimated 65% of heart failure patients belong to the 65 to 79years or 80-years and older age categories (Heidenreich et al., 2013).
Adding to this dilemma is the fact that the proportion of elderly individuals residing within
the United States is increasing at a greater rate than the total population, with the greatest
increases observed in the oldest age categories (Vigen, Maddox, & Allen, 2012). Census data
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from 2000 to 2010 indicated that the total US population increased by 9.7%, while individuals
age 65 years and above increased by 15.1%. Groups of individuals age 85 to 94 years and
those greater than 95 years of age increased exponentially by 29.9% and 25%, respectively
(United States Census Bureau, 2012; Vigen et al., 2012). The increasing age of the US
population, combined with the pervasiveness of comorbid conditions and unhealthy lifestyle
choices, will likely lead to an increased prevalence of future heart failure diagnoses (Vigen et al,
2012; Heidenreich et al., 2013).
Incidence and Prevalence. Secondary to the aging US population, increased
prevalence of comorbid conditions, advanced treatment modalities and improved outcomes for
heart failure patients, both the incidence and prevalence measures of heart failure are
continuously increasing. Heart failure has become a significant public health concern both in the
United States and globally, reaching pandemic proportions. Worldwide, 26 million people suffer
from heart failure (Benjamin et al., 2019). Nationwide, 6.2 million US residents are afflicted with
heart failure, a number that will continue to rise rapidly as the incidence of heart failure
increases by approximately 915,000 new cases annually (Fitch et al., 2017). It is estimated that
the overall prevalence of heart failure in the US is projected to increase by 46%, resulting in
approximately 8 million US adults living with heart failure by the year 2030 (Heidenreich et al.,
2013).
Relatedly, because both heart failure diagnosis and benefit eligibility for Medicare
services are correlated with advancing age, an overwhelming majority of heart failure patients
are Medicare beneficiaries, age 65 years or greater (Fitch et al., 2017). A prevalence rate of
10.5% is experienced by this age group with costs related to care disproportionately accounting
for 33.2% of the total Medicare expenditure (Fitch et al., 2017).
Lastly, over 75 million people, or 1 in 3 US adults have Stage A heart failure secondary
to chronic conditions and lifestyle risk factors (Kovell, Juraschek, & Russell, 2015). Without early
and aggressive intervention against comorbid conditions or lifestyle modifications, as the US
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population continues to age, patients will progress into more advanced stages of heart failure,
further adding to the financial burden of the disease.
30-day Readmission Rates
Hospital readmission is defined as, “an unplanned inpatient admission for any cause,
within 30 days from the date of discharge from the index of heart failure admission” (CMS,
2020b, p. 1). Due to the progressive nature of the disease, symptom exacerbation can occur
frequently in patients with heart failure, often requiring inpatient management focused on
aggressive diuresis and hemodynamic stabilization (Heidenreich et al., 2013). The cyclical
pattern of symptom manifestation often leads to the need for rehospitalization shortly after
discharge from an inpatient setting, with an estimated 21.9% (CMS, 2020a) to 23.5%
(Dharmarajan et al., 2017) of patients requiring hospital admission within 30 days of primary
hospitalization. In a retrospective observational study of 86,219 Medicare beneficiaries,
researchers evaluated the likelihood of hospital readmission for patients who were hospitalized
with the diagnosis of heart failure (Kilgore et al., 2017.) They found that 22.3% (n = 11,296) of
previously hospitalized patients were re-admitted for the same diagnosis within 30 days (Kilgore
et al., 2017).
Cost of care
Inpatient management of heart failure is significantly more expensive than care provided
in the outpatient setting. Despite recent incentives to decrease hospitalization costs, heart
failure remains the 3rd most expensive condition to manage in the inpatient setting (Liang,
Moore, & Soni, 2020). Despite this, nearly 80% of heart failure exacerbation management
nonetheless takes place in the inpatient setting. Fitch, Lau, Engel, Medicis, Mohr, & Weintraub
(2018) quantified the amount of money that can be saved if only 10% of would-be
hospitalizations were shifted to the outpatient setting. It is estimated that even this seemingly
small reduction in inpatient hospitalizations could result in a savings range of $667.5 million to
$1.49 billion (Fitch et al., 2018).
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Affordable Care Act
In 2012, in effort to combat out-of-control hospitalization and readmission rates and
related healthcare utilization costs, the US government instituted the Affordable Care Act (ACA)
to increase the availability of Medicare services and to decrease Medicare costs (CMS, 2020b).
Section 3205 of the ACA includes a description of the Hospital Readmission Reduction Program
(HRRP) (CMS, 2020c). The purpose of this value-based purchasing program is to link Medicare
reimbursement that health care organizations receive, to quality-of-care measures (CMS,
2020c). Thirty-day readmission rates are a key measurement used to evaluate the performance
of healthcare organizations. Those with high 30-day readmission rates compared to national,
state, and local peer groups, are penalized a portion of Medicare reimbursement funds, up to a
3% reduction (CMS, 2020b; Kilgore et al., 2017). Prior to the passage for the ACA and the
HRRP, healthcare organizations had little incentive to prevent hospital readmissions, because
Medicare reimbursement was related to admission diagnosis regardless of readmission status
(Mcllvennan, Zubin, & Allen, 2016). However, in the first two years of the program, US
healthcare organizations were fined a total of $507 million for excessive readmission rates
(Mcllvennan et al., 2016). This alarming negative incentive provoked the need for heart failure
management interventions to be implemented in the outpatient setting. Primary and secondary
prevention measures can and should be effectively implemented within the outpatient setting,
limiting the need for more expensive inpatient treatment for advanced disease stages
(Mcllvennan et al., 2016).
National Data. Recent estimates indicate that the prevalence of heart failure amongst
US Medicare beneficiaries in a fee-for-service population is 13.9% (CMS, 2018). This estimate
is expected to increase substantially as the American population continues to age and struggle
with comorbid conditions. Prevalence data correlates with the national rate of 30-day
readmissions for patients who have heart failure. The national readmission rate for heart failure
patients, based on cumulative data from June 2013 to July 2016 is 21.6%, a value that is
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expected to increase at the next 3-year review period, which is currently underway (CMS,
2019). All national healthcare organizations included in the inpatient prospective payment
system (IPPS) will be compared to this national standard and to those of local peer group
organizations.
State Data. Secondary to Indiana residents’ high rates of coronary artery disease,
hypertension, obesity, and diabetes mellitus, Hoosiers have an estimated 15% (CMS, 2018)
heart failure prevalence rate that exceeds the national rate. Despite multiple efforts to decrease
hospital readmission secondary to heart failure symptomatology, 30-day readmission rates
remain at an estimated 21.1%, a value comparable to national data (CMS, 2019). Heart failure
remains one of the most financially burdensome chronic illnesses within the state of Indiana,
with the cost of annual disease management averaging around $28,559 per Medicare
beneficiary (CMS, 2019). In recent years, Indiana healthcare organizations have struggled to
decrease hospital readmissions and associated costs. In 2019, secondary to soaring all-cause
readmission rates, a total of 66 Indiana hospitals were fined a portion of Medicare
reimbursement funds, totaling $12 million, a value that has increased by $9 million over the
previous three years (Russell, 2018).
Local Data. Prevalence data and 30-day readmission data were collected and evaluated
for three Northwest Indiana region counties. Lake county, Indiana’s second most heavily
populated county (US Census Bureau, 2020) experiences a heart failure prevalence rate of
18.7%, well above the national rate (CMS, 2018), with a 30-day readmission rate of 23%, also
grossly above national estimates (CMS, 2019). Porter county, the 9th most densely populated
Indiana county (US Census Bureau, 2020) experiences a heart failure prevalence rate of 16%
(CMS, 2018) and a 30-day readmission rate of 20% (CMS, 2019), slightly lower than the
national average (CMS, 2020). Lastly, LaPorte county, the 16 th most densely populated county
in Indiana (US Census Bureau, 2020) experiences a heart failure prevalence rate of 14.4%
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(CMS, 2018), and a 30-day readmission rate of 22% (CMS, 2019), both exceeding national
standards.
Data from the Clinical Agency Supporting Need for the Project
This EBP project is a pilot program that was implemented in a small, rural, for-profit
hospital in the northwest Indiana region. Continued program maintenance took place within the
outpatient setting. The patient population consisted of a lower socioeconomic status, and
Medicare was a large payer source (IU Health, 2016). To meet requirements of the HRRP,
organizations must calculate the annual expected readmission rate, based on a risk stratification
system. Expected readmission rate is the count of expected readmissions divided by the count
of index hospital stays. In a data collection date range spanning from July 1, 2015 through June
30, 2018, this organization expected 21.4 readmissions, but experienced 64 total readmissions
(CMS, 2020d), well above national, state, and local rates. Notably, in 2018, the organization
was fined a total of 1.18% of Medicare reimbursement funds, ranking it the 10th highest
penalized organization in the state (Russell, 2018). This poor-quality outcome was the impetus
for this EBP project.
Purpose of the Evidence-Based Practice Project
Due to the disproportionate amount of healthcare resources and Medicare expenditure
utilized for the treatment of preventable 30-day readmissions secondary to heart failure
exacerbation, an effective intervention to prevent the need for readmission is required. Although
there are evidence-based protocols available for the appropriate and most effective use of
pharmacologic measures to prevent heart failure exacerbations and thus readmissions,
previous nonpharmacologic methods have proven unsuccessful in decreasing readmission
rates. Evidence supports the use of telehealth platforms in the daily management of chronic
diseases such as heart failure (Gorodeski et al., 2020; Kitsiou, Paré, & Jaana, 2015; Kotb,
Cameron, Hsieh, & Wells, 2015; Lin, Yuan, Huang, & Zhang, 2017; Dadosky et al., 2018;
Hamilton, Mills, Birch, & Thompson, 2018; Frederix et al., 2019; Rosen, McCall, & Primack,
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2017; Aronow & Shamliyan, 2018; Clark, 2018). The purpose of this evidence-based practice
project was to determine the effectiveness of a smartphone MHA, HF Path (AHA, 2020), in
decreasing 30-day readmission rates related to heart failure.
PICOT Question
Specifically, this project addressed the following PICOT question: In adult Medicare
beneficiaries who have a diagnosis of heart failure with recent hospitalization (P), does the
implementation of an interactive smartphone application, HF Path® (I), compared to standard
office protocol (C) decrease 30-day readmission rates (O) over an eight-week period (T)?
Significance of the EBP Project
Heart failure is a disease that affects 6.2 million Americans (Fitch et al., 2017). The cost
of 30-day hospital readmissions secondary to this chronic disease consumes 2.3% of the total
Medicare annual expenditure (Fitch et al., 2017), a cost that is largely preventable with daily
disease management (AHA, 2017). The pay-for-performance and value-based purchasing
models of US healthcare have required healthcare organizations to discover alternative ways to
manage chronic conditions that are (a) relatively inexpensive to operate and maintain, and (b)
that can be implemented in the outpatient setting. There is growing support for the use of
telehealth platforms in the management of chronic conditions, such as heart failure (Gorodeski
et al., 2020; Werhahn, Dathe, Rottmann, Franke, Vahdat, Hasenful, & Seidler, 2019; Athilingam,
Labrador, Remo, Mack, San Juan, & Elliott, 2016; Foster, 2018, Cajita, Hodgson, & Budhathoki,
2017). The American Association of Nurse Practitioners (AANP) recently distributed a position
statement in support of telehealth management for chronic disease management (2019). In
short, the position statement reads, “Health care provided via technology should be recognized,
regulated and reimbursed on parity with the same services delivered in person” (AANP, 2019,
p.1).
Recent world events, such as the occurrence of the global health pandemic stemming
from the uncontrollable transmission of the novel Coronavirus, have increased the demand for
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telehealth practices (Gorodeski et al., 2020). Social distancing remains the only effective
measure to prevent the transmission of illness, thus outpatient clinics have begun using virtual
methods of data transmission to manage chronic conditions (Gorodeski, et al., 2020). These
measures help to prevent unnecessary patient and staff exposure to the virus. Multiple
technology platforms are being trialed for the treatment of heart failure. This chronic, debilitating
disease requires daily management and frequent intervention to prevent overwhelming
exacerbation of symptoms, thus an intervention to assist in daily monitoring should be available
to patients who suffer from the disease. Overwhelming disease exacerbations have beginnings
that are easily predictable secondary to fluctuations in vital signs that can be easily assessed by
patients in the home setting and transmitted to providers through a telehealth platform
(Gorodeski et al., 2020; Werhahn, Dathe, Rottmann, Franke, Vahdat, Hasenful, & Seidler, 2019;
Athilingam, Labrador, Remo, Mack, San Juan, & Elliott, 2016; Foster, 2018, Cajita, Hodgson, &
Budhathoki, 2017). Evidence suggests that intervention implemented at the earliest sign of
symptom exacerbation is the greatest combatant of decompensation and subsequent
hospitalization (AHA, 2017). By using telehealth platforms, providers can receive daily patient
data and react to early symptoms of exacerbation through medication adjustment to potentially
prevent the need for inpatient management, and subsequent healthcare utilization costs (AHA,
2017).
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CHAPTER 2
EBP MODEL AND REVIEW OF LITERATURE
Evidence-based Practice Model
Overview of EBP Model
The Iowa Model Revised: Evidence-Based Practice to Promote Excellence in Health
Care was used to organize and develop this evidence-based project. The original version of the
Iowa model, titled the Iowa Model of Research-Based Practice to Promote Quality Care, was
developed and implemented at the University of Iowa in 1994 (Titler et al., 2001). At its
inception, the model was used to assist nurses to transfer research knowledge to the bedside to
improve patient care measures (Titler et al., 2001). The model has undergone several revisions,
secondary to feedback from users. First, the Iowa Model Revised has built-in feedback loops to
illustrate that implementation of research knowledge is fluid (Titler et al., 2001). Second, the
terminology used has changed to reflect the shift from research utilization to the implementation
of evidence-based practice initiatives (Titler et al., 2001). Lastly, changes in the healthcare
market, such as the measurement of quality indicators, the shift towards patient-centered care
models, and cost savings initiatives have increased the need to facilitate transfer of evidence
findings to clinical practice (Titler et al., 2001). Practitioners who question current practice
methods are encouraged to utilize this systematic approach to determine if there is a more
effective method to improve patient care or broader healthcare outcomes.
The Iowa Model Revised is composed of multiple sequential steps (I) identify triggering
issues or opportunities, (II) state the question or purpose, (III) form a team, (IV) assemble,
appraise, and synthesize body of evidence, (V) design and pilot the practice change, (VI)
integrate and sustain the practice change, and finally (VII) disseminate results (Dang, Melnyk,
Fineout-Overholt, Yost, Cullen, Cvach, Larabee, Rycroft-Malone, Schultz, Stetler, & Stevens,
2019). There are three built-in decision points following steps two, four, and five to help the
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clinician determine if (a) the topic is a priority, (b) there is sufficient evidence available to
determine best practice initiatives, and (c) the change is appropriate for adoption in practice
(Dang et al., 2019). The systematic approach of the Iowa Model Revised assists practitioners in
moving through the EBP process. The steps of the model provide an outline for project
development, implementation, data collection and interpretation. This model was chosen for this
EBP project because it is highly adaptable and allows for revisions throughout the course of the
project. Additionally, this model was chosen because it has been utilized in previous projects or
research initiatives that were designed to decrease healthcare costs (Titler et al., 2001). Prior to
initiation of the EBP project, approval to use the Iowa Model Revised was obtained from the
Iowa Model Collaborative, on August 5, 2020 (Appendix A).
Application of EBP Model to DNP Project
Step I
Displaying a spirit of inquiry, the project leader entered Step I of the Iowa Model Revised
and began to identify triggering issues and opportunities for improvement within the clinical site.
An opportunity for improvement in the prevention of 30-day hospital readmissions for patients
who have heart failure was identified. After review of 2019 CMS data (CMS, 2020d) for hospital
readmission rates, it was determined that the clinical site received the 10 th highest CMS
reimbursement fine in the state of Indiana, secondary to higher than average 30-day
readmission rates (Russell, 2018).
Step II
Step II of the Iowa Model Revised requires a statement of the clinical question or
purpose of the EBP project. The initial clinical question proposed by the project leader was:
What is the most accessible, feasible, sustainable, and cost-effective strategy that can be
utilized in the outpatient setting to decrease hospital readmission rates related to heart failure in
this practice setting? Best evidence provides moderate support for the use of telehealth
interventions, such as MHAs for the reduction or prevention of hospital readmission rates
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related to heart failure. The PICOT question was then modified. The project was designed to
address the following PICOT question: In adult Medicare beneficiaries who have a diagnosis of
heart failure with recent hospitalization (P), does the implementation of an interactive
smartphone application (MHA), HFPath® (I), compared to standard office protocol (C) decrease
30-day readmission rates (O) over an 8-week period (T)?
Following Step II of the Iowa Model Revised, there is a built-in decision point that
requires the project leader to determine if the topic is a priority for the organization. The project
was considered a priority secondary to the financial penalty imposed following higher than
average readmission rates.
Step III
Step III of the Iowa Model Revised involved forming a team. The team consisted of key
stakeholders such as, the heart failure registered nurse liaison, the advanced practice
registered nurse (APRN) who directs patient care at the outpatient heart failure clinic, five
cardiologists, nurse members of the transitional care team, the quality director, and members of
senior leadership. The members of this team were essential in the development,
implementation, and evaluation phases of this EBP project. Selection of team members who
were excited about the overall project helped to ensure the project’s success and longevity
(Titler et al., 2001).
Step IV
Step IV of the Iowa Model Revised involved assembling, appraising, and synthesizing
the body of evidence identified in the literature. An exhaustive literature search was conducted
to determine appropriate interventions that could effectively decrease heart failure-related 30day readmission rates. The level and quality of each piece of evidence was determined by
applying the concepts of the Hierarchy of Evidence ranking system (Melnyk & Fineout-Overholt,
2019) and the Rapid Critical Appraisal Checklists (Melnyk & Fineout-Overholt, 2005). There
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were a majority of Level I, high-quality pieces of evidence, which added to the strength of the
EBP recommended practice change.
After completion of Step IV of the Iowa Model Revised, there is another decision point
that requires the EBP project leader to determine if there is sufficient evidence to determine best
practice change recommendations (Dang et al., 2019). Evidence was further evaluated for
applicability and feasibility of implementation at the clinical site. Financial and time limitations
prevented the use of one subset of telehealth that involved the implantation of a pacemaker
defibrillator with internal monitoring capabilities. After removal of the evidence pertaining to
implantable devices, a large amount of high-quality evidence that supported the incorporation of
noninvasive telehealth modalities for the management of chronic conditions such as heart
failure remained.
Step V
Step V of the Iowa Model Revised involves the formulation of the project design and
piloting the practice change (Dang et al., 2019). Project design began after preliminary meetings
were held with key stakeholders to determine facility needs, priorities, and possible resources.
Based on the available literature, a best practice recommendation protocol was developed to
guide the implementation of the smartphone MHA project. Baseline heart failure hospitalization
and hospital readmission data were collected for the organization. The EBP project began with
the disbursement of provider educational materials to inform involved clinicians about the
practice change. Patients who have heart failure were then identified through chart review. Due
to COVID-19 restrictions, my interaction with individuals in the inpatient setting was limited. I
briefly met with patients who were admitted with symptoms of heart failure exacerbation and
shared an explanation of the EBP project. At this time, I collected contact information for
individuals who expressed an interest in participating in the project.
After participant enrollment and project implementation was complete, there was a
decision point built into the Iowa Model Revised. After collecting data and participant
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response(s) to the initial phases of the project, the project leader and appropriate stakeholders
must determine if the practice change is appropriate for adoption in practice. The applicability to
practice, feasibility of implementation, and financial factors related to the project were
considered to determine the appropriateness of practice change. Revisions of the initial project
design were made.
Step VI
Objectives included in Step VI of the Iowa Model Revised included reintegration of the
practice change and assessment of the sustainability of the project. After determination of
project feasibility, and potential project revision, it is essential to reintegrate the practice policy
and procedure to keep the project relevant with practitioners. Sustainability of the project
increased following positive outcomes and engagement of key stakeholders (Dang et al., 2019),
such as providers, the heart failure liaison, patients, and the transitional care staff.
Step VII
The seventh, and final step in the Iowa Model Revised is dissemination of results. After
comprehensive data collection and statistical analysis, project outcomes were presented at the
2020 Virtual Indiana Nursing Summit (Appendix B) sponsored by the Indiana Center for
Nursing, and at the Valparaiso University DNP presentation seminar.
Strengths and Limitations of EBP Model for DNP Project
The Iowa Model Revised has been used to guide a multitude of EBP projects. The
model’s popularity is likely due to the piecemeal progression of steps that offer the EBP project
leader detailed descriptions of each stage of the practice change process. This model was
selected to guide the EBP project because it is suited for use by a team, composed of the
project leader and key stakeholders. Due largely to the restrictions imposed by COVID-19
regulations, I was unable to provide extensive face-to-face education for inpatients, therefore,
the project’s success was reliant on the participation of other team members, and the
participants themselves. The steps of the model were easy to follow with clear, concise
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directions given for each step of the process. The built-in decision points incorporated
throughout the model allowed the project leader opportunities to continually review the work that
had been done and to determine if any project revisions were required. The use of the Iowa
Model Revised facilitated a logical progression through the EBP process. Fortunately, there
were no limitations to the model identified throughout the entirety of the EBP project.
Literature Search
Sources Examined for Relevant Evidence
A comprehensive, systematic search of the literature was performed in the following
databases: Joanna Briggs Institute (JBI), The Cochrane Database, Cumulative Index to Nursing
and Allied Health Literature (CINAHL), Turning Research Into Practice database (TRIP), and
Medline with Full Text. Keywords and phrases, MeSH terms, Boolean operators and truncation
included “heart failure” OR MM “heart failure” AND readmi* OR rehospitaliz* OR MM
“readmission” OR MM “patient readmission” AND reduc* OR decreas* OR minimize* OR lower*
OR prevent*. In addition to the searches completed within these databases, a thorough hand
search and citation chasing measures were performed to identify potentially appropriate pieces
of evidence that were not identified within original search results. Table 2.1 provides a summary
of the evidence search process and results obtained. Limiters applied included a date range
from June 2015 through June 2020, or current date; English language; scholarly, peer-reviewed
articles; and human subjects. The date limiter was applied to ensure that the most up-to-date
pieces of evidence were selected for use within the project.
The inclusion criteria encompassed the previously detailed limiters and also included
outpatient strategies that were effective in decreasing heart failure-related 30-day readmission
rates in adult Medicare beneficiaries who have a diagnosis of heart failure and a recent
hospitalization. The exclusion criteria included pieces of evidence which (a) were related to
pharmacologic heart failure interventions, (b) focused on pediatric heart failure patients, or (c)
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evaluated the effectiveness of implantable devices or surgical intervention for the management
of heart failure.
The JBI database search resulted in 54 pieces of evidence. After the application of
inclusion and exclusion criteria, nine abstracts were selected for further review. Ultimately, all
nine pieces of evidence were excluded. The pieces were all JBI evidence summaries or
systematic review protocols. The pieces were not selected for use within the literature review;
however, were added to support for the use of telehealth modalities in the chronic management
of heart failure. These pieces of evidence were used to citation chase and handsearch further
evidence.
The Cochrane Library search resulted in 41 pieces of evidence. After application of the
inclusion and exclusion criteria, five pieces of evidence were selected for further review. Three
pieces of evidence were omitted because of the focus on pharmacologic management of heart
failure. Ultimately, two Cochrane Reviews met inclusion criteria and were selected for use within
this literature review and EBP project.
The CINAHL database search resulted in 188 pieces of evidence. Nine pieces of
evidence were duplications. After application of inclusion and exclusion criteria, 15 pieces of
evidence were selected for further review. Ultimately four pieces of evidence met inclusion
criteria and were selected for use within this literature review and EBP project.
The TRIP database search resulted in 70 pieces of evidence. Four results were
duplicates, and thus were omitted. After application of inclusion and exclusion criteria, five
pieces of evidence were selected for thorough review. Ultimately, one US guideline was
selected for inclusion within this literature review and EBP project.
The Medline with Full Text database search resulted in 32 pieces of evidence. Two
results were duplicates, and thus were removed. After application of inclusion and exclusion
criteria, 11 pieces of evidence were selected for thorough review. Ultimately, three pieces of
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evidence met inclusion criteria and were selected for use within this literature review and EBP
project.
In addition to the database searches, citation chasing and handsearching procedures
were utilized to identify alternative pieces of evidence that were not represented within the
original database searches. Fifteen pieces of evidence were citation chased from initial articles
identified within the database searches, resulting in a thorough review of nine additional pieces
of evidence. Finally, three further pieces of evidence published within the “Journal of Cardiac
Failure” were identified through handsearching and thoroughly reviewed. Ultimately, five pieces
of evidence, identified through citation chasing, and one piece of evidence, identified through
handsearching, met inclusion criteria, and were selected for inclusion within this literature review
and EBP project.
Overall, the total literature search process (Figure 2.1) yielded 403 results; however, 15
pieces of evidence were duplicates. Fifty-seven total abstracts were reviewed, and 33 pieces of
evidence underwent thorough full-text review. After the completion of the comprehensive
literature search, a total of 16 pieces of evidence were selected for use within this EBP project.
On June 10, 2020, a virtual meeting was held with the Valparaiso University School of Nursing
research librarian. Literature search process approval was obtained on June 24, 2020.
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Table 2.1
Literature Search Results
Database/Resource Searched

JBI

Keywords/Phrases
Used

Limiters

Results Yielded

Duplicates

Abstracts Reviewed

Articles Used

“heart failure”
AND
readmi* OR rehospitaliz*

2015-2020

54

0

9

0

MeSH descriptor [heart failure]
– explode all trees

2015-2020
Cochrane Reviews

41

0

5

2

CINAHL

MM “heart failure”
MM “readmission”
Reduc* OR decreas* OR
minimiz* OR lower* OR
prevent*

2015-2020
English Language
Scholarly, peer-reviewed
Research article

188

9

15

4

TRIP

(“heart failure”) AND
(“readmission” OR
“rehospitalization”) AND
(reduc* OR decreas* OR
minimiz* OR lower* OR
prevent*)

“Since 2015”
USA Guidelines

70

4

5

1

(MM “heart failure+”) AND
(MM “patient readmission”)
AND
Reduc* OR decreas* OR lower*
OR prevent*

2015-2020
English Language
Scholarly, peer-reviewed

32

2

11

3

Citation Chasing

N/A

N/A

15

N/A

9

5

Handsearching

N/A

N/A

3

N/A

3

1

Total

N/A

N/A

403

15

57

16

Cochrane

MEDLINE
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Levels of Evidence
The Melnyk and Fineout-Overholt Hierarchy of Evidence ranking system (2019) was
used to evaluate and classify the 16 pieces of evidence selected for use within this EBP project.
Pieces of evidence are evaluated for strength, quality, consistency, generalizability, and risk for
bias (Fineout-Overholt & Stevens, 2019). Pieces of evidence are categorized into one of seven
levels: (Level I) systematic reviews, (Level II) randomized controlled trials (RCTs), (Level III)
nonrandomized controlled trials, (Level IV) controlled cohort studies, (Level V) uncontrolled
cohort studies, (Level VI) case studies and case series, qualitative and descriptive studies, EBP
implementation and quality improvement (QI) projects, and (Level VII) expert opinion, which are
visually displayed in a pyramid structure with higher quality evidence receiving a lower
numerical label (O’Mathúna & Fineout-Overholt, 2019). Levels near the peak of the pyramid
(levels I, and II) are more generalizable and have a lower risk for bias (O’Mathúna & FineoutOverholt, 2019).
Appraisal of Relevant Evidence
The Fineout-Overholt and Melnyk Rapid Critical Appraisal Checklists (RCACs) (2005)
were used to evaluate 10 systematic reviews, three RCTs, and one evidence-based guideline,
that were selected for use within this EBP project. The RCACs offer a succinct and
straightforward method for thoroughly evaluating the chosen pieces of evidence. The checklists
are divided into three sections, with yes or no response questions related to the validity,
reliability, and applicability of the piece of evidence (Fineout-Overholt & Melnyk, 2005). Users
can quickly and accurately evaluate the quality of a piece of evidence. This method of
evaluation was chosen because of the specific section that addresses applicability. After a piece
of evidence is deemed appropriate or relevant for the project, the applicability must be
evaluated. If the intervention supported within the evidence is not feasible within practice facility,
the evidence is not appropriate for that patient population. The only disadvantage of using the
RCACs is that there is no rating system detailed. Therefore, it is necessary for the evaluator to
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create a rating system based upon the results of the questions included within the checklist. For
this project, a quality ranking system consisting of three categories: (a) high quality, (b) good
quality, and (c) low quality, was implemented. High quality pieces of evidence have a sufficient
sample size, adequate controls, consistent recommendations, and generalizable results. Pieces
of evidence received a good quality rating if there were sufficient sample sizes, appropriate
controls, fairly definitive conclusions and reasonably consistent results. Lastly, pieces of
evidence received a low-quality rating when there were large flaws observed in the research
process, insufficient sample sizes, inconsistent results, and lack of generalizable findings.
Although there is no perfect evaluation tool for assessing quality of evidence, the RCACs offer a
simple, and effective approach for determining the validity, reliability, and applicability of a piece
of evidence (Fineout-Overholt, & Melnyk, 2005).
Step four of the Iowa Model-Revised guided the literature search and evidence synthesis
for this EBP project. After evaluating the selected pieces of evidence and the applying the
provisions of the Melnyk and Fineout-Overholt Hierarchy of Evidence ranking system (2019),
and the RCACs, nine systematic reviews (SR) were rated as Level I, high-quality; one SR was
rated as Level I, good-quality; two pieces of evidence, including one small-scale SR, and one
large RCT, were rated as Level II, high quality; one RCT was rated as Level II, good quality; one
nonrandomized trial was rated as Level III, high quality; one small-scale SR was rated as Level
III, good quality; and the one remaining piece of evidence, a policy statement from the AHA,
was rated as Level VII, high quality. The completion of the systematic literature search and
subsequent evidence synthesis helped to form a foundation for the EBP project and move the
project onto step three of the Iowa Model-Revised. Table 2.2 provides a summary of each piece
of evidence selected for inclusion in this evidence-based practice project.
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Table 2.2
Evidence Synthesis
Citation

Purpose

Flodgren, G., Rachas, A., Farmer, A. J., Inzitari, M., &
Shepperd, S. (2015). Interactive telemedicine: Effects
on professional practice and health care outcomes.
Cochrane Database of Systematic Reviews.
https://doi.org/10.1002/14651858.CD002098.pub2

“to assess the
effectiveness,
acceptability, and
costs of interactive
telemedicine (TM) as
a alternative to, or in
addition to usual
care” (p. 1)

Inglis S. C., Dierchx, R., Prieto-Merino, D., & Cleland,
J. F. (2015). Structured telephone support or noninvasive telemonitoring for patients with heart failure.
Cochrane Database of Systematic Reviews.
https://doi.org/10.1002/14651858.CD007228.pub3

“to review RCTs of
structured telephone
support or noninvasive home
telemonitoring
compared to
standard practice for
people with heart
failure, in order to
quantify the effects of
these interventions
over and above usual
care” (p.9)

Design

Cochrane
Review

Cochrane
Review

Sample

Measurement/
Outcomes

93 RCTs
36 of which
were specific
to
cardiovascular
disease
(N = 22,047
participants)
published
between
1992-2013

IV: TM
interventions
(varied between
studies – all fit
into the following
2 categories:
remote
monitoring
[including mobile
phone
applications] or
Video
conferencing)
delivered in a
home setting

41 RCTs
published
between
1999-2014
25 studies
focused on
structured
telephone
support (STS)
18 studies
focused on
telemonitoring
(2 studies
evaluated
both
interventions
– included in
both counts)

DV: all-cause
mortality, hospital
admission, and
QOL
IV: non-invasive
remote
telemonitoring
OR structured
telephone
support
DV: all-cause
mortality, HFrelated
readmission, allcause
readmission

Results/Findings

11 studies focused on hospital
admission (HF-related)
RR (0.36 – 1.60, 95% CI) ranged
from a decrease of 64% to an
increase of 60% at a median 8
months follow up
(moderate certainty of evidence) –

Level/
Quality
Level I;
High quality

high level of statistical heterogeneity
16 studies reported HF-related
hospital readmission; 3 studies
reported reduction in readmission
and 13 studies reported no
difference between groups

Non-invasive remote telemonitoring
reduced all-cause mortality (RR 0.80
95% CI 0.68-0.94) 17 RCTs
(N=3740 participants)
Non-invasive remote telemonitoring
reduced HF-related hospitalizations
(RR 0.71 95% CI 0.60-0.83) 8 RCTs
(N=2148) – overall reduction of 29%
compared to usual care
Effective technologies to transfer
remote telemonitoring data
Telephone (RR 0.76 95%CI 0.670.86)
Mobile Phone/PDA (RR 0.58 95% CI
0.44-0.77) 3 RCTS (N=674)
Structured telephone support (STS)
reduced all-cause mortality (RR 0.87
95% CI 0.77-0.98) 22 RCTs
(N=9222)

Level I;
High quality
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STS also reduced HF-related
hospitalizations (RR 0.85 95% CI
0.77-0.93) 16 RCTs (N= 7030)

Kitsiou, S., Paré, G., & Jaana, M. (2015). Effects of
home telemonitoring interventions on patients with
chronic heart failure: An overview of systematic
reviews. Journal of Medical Internet Research 17(3),
1-30. http://doi.org/10.2196/jmir.4174

The authors
identified, evaluated,
and synthesized
information within
systematic reviews
about various forms
of home
telemonitoring and
the impact on allcause and HFrelated
rehospitalization and
all-cause mortality for
patients with heart
failure

Overview of
systematic
reviews;
meta-level
synthesis

15 systematic
reviews
published
between 2003
– 2013

7 SRs examined
the effect of HT
on HF-related
hospitalization
IV: various forms
of telemonitoring
– video
consultation,
automated
device-based
telemonitoring,
web-based
telemonitoring,
interactive voice
response
systems, &
mobile
telemonitoring
Vs. usual care
No uniform
timeframe
DV: all-cause
mortality: allcause
hospitalization;
HF-related
Hospitalization

Kotb, A., Cameron, C., Hsieh, S., & Wells, G. (2015).
Comparative effectiveness of different forms of
telemedicine for individuals with heart failure (HF): A
systematic review and network meta-analysis. PLoS
ONE 10(2), 1-15.
http://doi.org/10.1371/journal.pone.0118681

“to determine
whether remote
monitoring strategies
can improve
outcomes for adults
who have been
recently discharged
following an
unplanned admission
due to acute heart
failure” (p. 2)

Systematic
Review and
Network
Meta-Analysis

30 RCTs
published
between
1998-2012
21 studies
observed
participants
for less than 6
months; 19
studies
observed

Neither intervention demonstrated
effectiveness in reducing all-cause
hospitalization
All 7 SRs reported beneficial effects
with HT

Level I;
High quality

Overall RR reduction ranged from
14% (HR = 0.86 [95% CI 0.61-1.21])
to 36% (HR = 0.64 [95% CI 0.341.14])
ARR in HF-Related hospitalization
extended from 3.7% to 8.2%
“improvements may be more
pronounced in patients with stable
HF receiving telemonitoring with
clinical support 24/7 (HR 0.64 95%
CI 0.34-1.14) (p. 12)
Overall quality of evidence low,
results statistically inconclusive
Mobile telemonitoring
HF-related hospitalization
RR reduced by 28%
(RR = 0.72 [0.42-1.26], P=0.25) –
statistically inconclusive due to small
sample sizes

IV: Structured
telephone
support (STS);
Video monitoring;
ECG monitoring;
STS +
telemonitoring;
telemonitoring

HT interventions without home visits
resulted in 21% relative risk
reduction of HF-related
hospitalization (RR= 0.79 [0.690.91], P=.001)
“STS (OR 0.69 95% CI 0.56-0.85),
telemonitoring interventions (OR
0.64 95% CI 0.39-0.95), and
telemedicine that included the
transmission of ECG data (OR 0.71
95% CI 0.52-0.98) all significantly
reduced HF-related hospitalizations
compared to usual care” (p.9)

DV: all-cause
mortality; allcause

Telemonitoring was also effective at
reducing all-cause mortality (OR
0.53 95% CI 0.36-0.80).

Level I;
High quality
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Bashi, N., Karunanithi, M., Fatehi, F., Ding, H., &
Walters, D. (2017). Remote monitoring of patients
with heart failure: An overview of systematic reviews.
Journal of Medical Internet Research 19(1), 1-14.
http://doi.org/10.2196/jmir.6571

Lin, M., Yuan, W., Huang, T., Zhang, H., Mai, J., &
Wang J. (2017). Clinical effectiveness of telemedicine
for chronic heart failure: A systematic review and
meta-analysis. Journal of Investigative Medicine 65,
899-911. http://doi.org/10.1136/jim-2016-000199

Synthesis of
evidence within
systematic reviews
pertaining to remote
patient monitoring
interventions and the
effect(s) on outcomes
for patients who have
heart failure

“to comprehensively
review the literature
and provide an
update on the
effectiveness of
telemedicine for
treating patients with
CHF” (p. 900)

Overview of
systematic
reviews

Systematic
review and
meta-analysis

27
participants
for more than
6 months
19 systematic
reviews
published
between
2006-2015

39 RCTs
published
between
1999-2013

hospitalization;
heart failure
hospitalization
IV: Information
and
communication
technology
interventions
(telephone
support, video
monitoring,
mobile phone
applications,
telemonitoring)
DV: health
knowledge, selfcare, health
status/well-being,
rehospitalization,
ER visits, LOS
IV: any type of
home-based
telemedicine
combined with
usual standard
care –
transmission of
physiologic
signs/symptoms
(HR, BP, weight
changes)
2 IV groups
divided based on
the type of
interventions:
teletransmission
(n=21) and
telephonesupported care
(n= 21) (some
studies were
included in both
groups)
Control: usual
care only –
guideline based

Telemonitoring did not reduce allcause hospitalization at a level of
statistical significance
Telemonitoring including the
physiologic monitoring of BP, HR,
weight, and ECG was effective at
decreasing HF-Related mortality and
Hospitalization and all-cause
hospitalization. Telemonitoring also
improved patient QOL.

Level I,
High quality

Mobile phone-based interventions
did not have a statistically significant
reduction in HF related outcomes –
possibly due to small sample size

Compared to the control group, the
rate of HF-related admission rate
was significantly lower in the overall
telemedicine group
Pooled OR = 0.63, 95% CI 0.530.76, Z = -4.91, p<0.001
Teletransmission group Pooled OR =
0.61, 95% CI 0.42-0.88, Z=-2.64, p =
0.008
Telephone-supported care group
Pooled OR = 0.64, 95% CI 0.520.79, Z = -4.15, p <0.001

Level I;
High quality
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Aronow, W. S., & Shamliyan, T. A. (2018).
Comparative effectiveness of disease management
with information communication technology for
preventing hospitalization and readmission in adults
with chronic congestive heart failure. Journal of the
American Medical Directors Association 19, 472-479.
https://doi.org/10.1016/j.jamda.2018.03.012

Clark, R. A. (2018). Telehealth in the elderly with
chronic heart failure: What is the evidence?
Telehealth for our Aging Society, 18-23.
https://doi.org/10.3233/978-1-61499-845-7-18

Hamilton, S. J., Mills, B., Birch, E. M., & Thompson,
S. C. (2018). Smartphones in the secondary
prevention of cardiovascular disease: A systematic
review. BMC Cardiovascular Disorders 18(25), 1-23.
https://doi.org/10.1186/s12872-018-0765-x

“to appraise all
available evidence
regarding the role of
noninvasive
communication
technology for
improving patient
survival and reducing
hospital admissions
in adults with chronic
heart failure” (p. 472).

To summarize
available evidence
about the effect of
telemonitoring on
heart failure
outcomes in elderly
patients with the
disase

To examine
smartphone
interventions for
comprehensive
cardiac rehab
services and how
people in rural

Systematic
Literature
Review &
Meta-analysis

Systematic
review

Systematic
Review

28

2 metaanalyses and
58 RCTs
published
through 2018

43 RCTs

3 RCTs (level
II) and 1
feasibility
study (level
IV) published
2006-2014

DV: all-cause
hospital
admission rates;
HF-related
hospital
admission rates;
length of hospital
stays; and
mortality
IV: noninvasive
telemonitoring
including remote
monitoring of
patient BP,
weight, pulse
oximetry, ECG,
and symptoms
through digital
transmission
DV: mortality;
hospital
admission,
hospital
readmission
IV: telemonitoring
intervention –
electronic
transfer of
physiologic data:
BP, ECG, weight,
pulse, oximetry,
respiratory rate,
medication
administration
DV:
rehospitalization,
mortality,
adherence,
satisfaction, cost
effectiveness,
QOL
IV: Patient status
monitoring in
addition to
standard care vs.
standard care
alone

Telemonitoring prevents 60 HFrelated hospitalizations per 1000
treated adults and that it prevents
215 HF-related hospitalizations per
1000 treated older adults
(RR = 0.74, 95% CI, 0.62-0.88).

Level I;
High quality

Providers should offer noninvasive
telemonitoring to reduce HF-related
admissions or readmissions

Non-invasive telemonitoring reduced
heart failure-related hospitalizations
(RR 0.75, 95% CI, 0.63-0.91, p =
0.003)

Level I;
Good
quality

Non-invasive telemonitoring did not
reduce all-cause hospitalizations

Telemedicine system integrated care
through mobile phone – participants
entered BP and weight daily. Data
were entered into templates on the
mobile phone application and
automatically sent – emails were

Level I;
High quality
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settings can benefit
from the use of the
technology

DV: rehospitalization for
worsening heart
failure symptoms

sent to study physicians if data were
outside of allowable parameters
Daily data entry took approximately 2
minutes per day and participants rate
that as acceptable
Telemonitoring was demonstrated to
be feasible and acceptable with high
patient adherence
“Telemonitoring has the potential to
reduce hospital service utilization
through lowering frequency and
duration of hospitalizations” (p. 19)
54% RRR of hospitalization for the
telemonitoring group compared to
the control group after 6 months of
intervention
(95% CI; p = .04)
CG 17 hospitalizations; TMG 11
hospitalizations
mHealth was comparable to
traditional HF treatment methods

Pekmezaris, R., Tortez, L., Williams, M., Patel, V.,
Mararyus, A., Zelster, R., Sinvani, L., Wolf-Klein, G.,
Lester, J, Sison, C., Lesser, M., & Kozikowski, A.
(2018). Home telemonitoring in heart failure: A
systematic review and meta-analysis. Health Affairs
37(12), 1983-1989.
https://doi.org/10.1377/hlthaff.2018.05087

Cajita, M. I., Gleason, K. T., & Han, H. R. (2016). A
systematic review of mHealth-based heart failure
interventions. Journal of Cardiovascular Nursing
31(3), e10-e22.
http://doi.org/10.1097/JCN.0000000000000305

“examine the impact
of the duration of
monitoring as well as
the provision of home
care and provide
policy makers with a
new look at how HTM
affects all-cause
versus heart failure
specific utilization
and mortality” (p.
1984).

Systematic
review and
meta-analysis

To describe currently
available mHealth
interventions and the
effect of those
interventions on HF
outcomes

Systematic
review

26 RCTs
published
between
2001-2016

IV: home
telemonitoring
interventions that
include patient
submitted daily
data
DV: all cause
hospitalization;
heart failure
related
hospitalization at
180-days

10 studies
published
between
2006-2015
6 = RCTs

IV: mHealth
interventions with
various
monitoring
devices including
mobile devices,

mHealth improved access for
patients unable to attend in-person
appointments
Home telemonitoring did not have a
significant impact on the odds of all
cause hospitalization at 180 days
(OR 0.97 CI 95% p = 0.902)

Level I;
High quality

Home telemonitoring did not have a
significant impact on the odds of
heart failure related hospitalization at
180 days (OR 0.69 CI 95% p =
0.112)
Home telemonitoring can lead to
early recognition of exacerbation
symptoms that can be successfully
managed in the outpatient setting
None of the monitoring interventions
had a significant impact on the DVs
Neither invasive nor non-invasive
monitoring interventions significantly

Level II;
High quality
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4 = Quasiexperimental
Study duration
ranged from 4
weeks to 24
months

Rosen, D., McCall, J. D., & Primack, B. A. (2017). A
telehealth protocol to prevent readmission among
high-risk patients with congestive heart failure. The
American Journal of Medicine 130(11), 1326-1330.
https://doi.org/10.1016/j.amjmed.2017.07.007

“to assess protocol
adherence in a highrisk sample, to
compare adherence
across a range of
patient
characteristics, and
to assess
intervention efficacy”
(p. 1327)

RCT

50 patients
with the
diagnosis of
CHF and at
least 1 ER
visit or
hospitalization
within the
previous 3
years
Study
duration: 6
months

wireless data
receivers, ECG
recorder, BP
device, Weighing
scale,
implantable
defibrillator,
information
transfer device
DV: all-cause
mortality, CV
mortality, HFrelated
admissions,
LOS, NYHA
class, LVEF,
QOL, Self-care
IV: telehealth
intervention
requiring daily
patient report of
weight, BP, and
symptoms on a
supplied
touchscreen
tablet
Patient data was
sent to heart
failure trained
social workers
DV: participant
adherence - % of
days participants
successfully
completed
protocol
CHF-specific
admissions,
CHF-specific
readmissions, allcause
admissions, and
all-cause
readmissions
Control group:
admission and

decreased the occurrence of heart
failure related hospitalizations
Small sample sizes; inclusion of
quasi-experimental design studies

During the intervention period, there
were:
53% fewer CHF-specific admissions
(15 compared to 7) p = .007
83% fewer CHF-specific
readmissions
(6 compared to 1) p = .01
25% fewer all-cause readmissions
(32 compared to 24) p = .01
57% fewer all-cause readmissions
(14 compared to 6) p = .006

Level II;
Good
quality
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Frederix, I., Vanderlinden, L., Verboven, A., Welten,
M., Wouters, D., De Keulenaer, G., Ector, B.,
Elegeert, I., Troisfontaines, P., Weytjens, C., Mullens,
W., & Dendale, P. (2019). Long-term impact of a sixmonth telemedical care programme on mortality,
heart failure readmissions and healthcare costs in
patients with chronic heart failure. Journal of
Telemedicine and Telecare 25(5), 286-293.
https://doi.org/10.1177/1357633X18774632

Long, G., Babbitt, A., & Cohn, T. (2017). Impact of
home telemonitoring on 30-day hospital readmission
rates for patients with heart failure: A systematic
review. MedSurg Nursing 26(5), 337-348.

Dadosky, A., Overbeck, H., Barbetta, L., Bertke, K.,
Corl, M., Daly, K., Hiles, N., Rector, N., Chung, E., &
Menon, S. (2018). Telemanagement of heart failure
patients across the post-acute care continuum.
Telemedicine and e-HEALTH 24(5), 360-366.
https://doi.org/10.1089/tmj.2017.0058

“To assess whether
an initial 6-month
telemonitoring
program would result
in reduced all-cause
mortality, heart failure
admissions and
health care costs in
CHF patients at longterm follow-up” (p.
286)

“to determine the
effectiveness of
home telemonitoring
use on 30-day
hospital readmission
rates in patients with
HF”
(p. 337)
PICOT: In adult
patients with HF what
is the effect on 30day hospital
readmission rates of
implementing home
telemonitoring to
assist healthcare
providers in ongoing
care?
“to investigate
whether
telemanagement of
HF patients
throughout the postacute continuum of
care would reduce
hospitalization rates

Multi-centre,
randomizedcontrolled
telemonitoring
trial
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160 adult
patients who
have heart
failure
Control group
(n = 80)
Intervention
group (n = 80)
Study
duration: 6month initial
intervention,
follow-up at
6.5 years
postintervention

Systematic
review

6 studies
Published
between 2011
– 2016

readmission
rates during the 6
months prior to
the intervention
IV: telemonitoring
intervention
including remote
weight, BP, HR,
and symptoms
and provider
feedback
completed using
wireless or
broadband
connections
DV: days lost to
heart-failure
readmissions

IV: home
telemonitoring
intervention
(daily download
of weight, BP,
HR, and survey
answers)

Number of days lost due to heart
failure readmissions was significantly
lower in the telemonitoring group
(7.28 ± 12.55 days) compared to the
usual care group (11.81 ± 18.57
days) U = 2640, z = -2.04, p = 0.04

Level II;
High quality

Older CHF patients >75 yr. in the
telemonitoring group were
readmitted less frequently than
participants in the control group U =
905, z = -2.227, p = 0.026
CHF patients with less severe
disease (EF > 35%) who received
telemonitoring were readmitted less
frequently than participants in the
control group U = 659, z = - 1.97, p =
0.05
No statistically significant reduction
in HF-related 30-day readmission

Level III,
Good
quality

DV: 30-day
readmission
rates (related to
HF)
Control group:
usual postdischarge care

Prospective
nonrandomized
trial

138 total
participants
92 historical
participants
served as
control

Control: historical
group who
received
standard care (n
= 92)
Intervention
group: standard

Control group: 23.9% of patients
were readmitted within 30 days of
hospitalization
Intervention group: 8 patients
(17.39%) were readmitted within 30
days of hospitalization

Level III;
High quality
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and improve patient
self-care knowledge
and satisfaction” (p.
360)

32
46
intervention
group
participants

care plus
telemanagement
– video sessions,
POC laboratory
testing, vital sign
monitoring at
SNF or at home
daily x 30 days –
data uploaded on
smart tablet (n =
46)

“telemanagement can be used to
achieve reduced readmission rates
even in high-risk populations” (p.
366)

IV: Usual care +
Telemanagement
Control group:
Usual care

Schwamm, L. H., Chumbler, N., Brown, E., Berube,
D., Nystrom, K., Suter, R., Zavala, M., Polsky, D.,
Radhakrishnan, K., Lacktman, N., Horton, K.,
Malcarney, M. B., Halamka, J., Tiner, A. C. (2016).
Recommendations for the implementation of
telehealth in cardiovascular and stroke care.
American Heart Association.
file:///C:/Users/jcris/Desktop/NUR%20799/ResearchEvidence/TRIP/Schwam,%202016.pdf

“to provide a
comprehensive
review of the
scientific evidence
evaluating the use of
telemedicine in
cardiovascular and
stroke care and to
provide consensus
policy suggestions”
(p. 1)

Policy
Statement

N/A

DV: 30-day
readmission
rates (using
EHR)
N/A

Barriers to Implementation
Legal & regulatory: Reimbursement;
technological infrastructure; cost
Reimbursement: Medicaid coverage
for telehealth visits varies from state
to state – new coverage allowances
– requiring health plans to reimburse
telehealth visits at the same or
equivalent rates as in person visits
Lack of standardization of telehealth
practices across states
Patient privacy/confidentiality –
increased opportunity for privacy
breach
Cost of technology
Acquisition costs for low-end
technology system average
$305,000 to high-end system
$7,820,000 excluding installation
fees ranging from 156,000 to
625,000
The annual costs to maintain a
telehealth program within an

Level VII;
High quality
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outpatient office ranged from
$61,000 to $1,560,000
Digital isolation – rural/geographical
lack of technological infrastructure –
or lack of device – may perpetuate
decreased access to care in
underserved communities
Usability and other human factors:
older users can experience difficulty
when operating new technologies
due to cognitive conditions,
sensation or vision impairments and
decreased dexterity which could
delay reporting of symptoms and/or
treatment
Mobile platforms and Connected
Health
Mobile devices (smartphones) can
be used to transmit patient data in
real-time
Patients can monitor symptoms and
VS and quickly send that information
to the provider allowing for more
immediate response to urgent
symptoms of decompensation – this
practice encourages patient
involvement and strengthens the
patient-provider relationship
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Level I Evidence
Flodgren, Farmer, Inzitari, and Shepperd (2015). Flodgren, Farmer, Inzitari,
and Sheppard completed a comprehensive, Level I, high-quality Cochrane review to assess the
role that telehealth interventions can play in the management of chronic conditions. Telehealth
was defined as “the use of telecommunication to deliver healthcare at a distance” (Flodgren et
al., 2015, p. 1). Researchers evaluated and pooled outcomes data from a total of 93 RCTs
(N=22,047 participants) published between 1992 and 2013 (Flodgren et al., 2015). The RCTs
included in the review compared effectiveness and cost efficiency of interactive telehealth
modalities, such as remote monitoring and real-time videoconferencing, to usual care measures
(Flodgren et al., 2015). Patients with the following conditions were included in the RCTs and
subsequent Cochrane review: (a) cardiovascular disease, (b) diabetes, (c) respiratory
conditions, (d) mental health and substance abuse conditions, (e) conditions requiring a
specialist, (f) comorbidities, (g) urogenital conditions, (h) neurological injuries and conditions, (i)
gastrointestinal conditions, (j) neonatal conditions requiring a specialist, (k) solid organ
transplantation, and (l) cancer (Flodgren et al., 2015).
The role of telehealth interventions varied between RCTs; however, all studies could be
classified within one of the following categories: (a) monitoring of a chronic condition to detect
early signs of deterioration and prompt early treatment, (b) delivery of treatment or rehabilitation
interventions, (c) education, (d) specialist consults, (e) real-time assessment of clinical status,
and (f) screening for angina (Flodgren et al., 2015). Heart failure-related outcomes observed
included all-cause mortality at a median of six months follow-up, hospital admission at a median
of eight months follow-up, and quality of life (QOL) (Flodgren et al., 2015).
Researchers found no difference between groups for all-cause mortality for patients with
heart failure (16 studies, N = 5,239, RR=0.89, 95% CI, RR = 0.76 to 1.03) at a median of six
months (Flodgren et al., 2015). Hospital admissions for patients with heart failure ranged widely
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from a decrease of 64% to an increase of 60% (11 studies, N = 4,529, 95% CI RR = 0.36 to
1.60) at a median of eight-month follow-up, with moderate certainty of evidence (Flodgren et al.,
2015). Researchers also found some evidence of improved quality of life (QOL) compared to
usual care measures at a median of three-month follow-up (Flodgren et al., 2015). There was
insufficient evidence related to the cost of telehealth interventions as compared to usual care;
further studies will need to be completed to study this potential benefit. Overall, the findings
indicate that the use of telehealth interventions can lead to health outcomes similar to those of
face-to-face interventions or telephone care delivery methods in the care of patients with heart
failure (Flodgren et al., 2015).
Inglis, Clark, Dierckx, Prieto-Merino, and Cleland (2015). Inglis, Clark, Dierckx,
Prieto-Merino, and Cleland (2015) completed a Level I, high-quality, Cochrane review to study
the effects of implementing structured telephone support (25 studies, n = 9,332) and noninvasive telemonitoring (18 studies, n = 3,860) for patients with heart failure (Inglis et al., 2015).
Two additional studies evaluated the combination of the two interventions. Forty-three RCTs
published between 1999 and 2014 were included for review. This study was specific to patients
with chronic heart failure. Researchers conducted the study to determine if telehealth measures
were comparable to face-to-face interventions for decreasing all-cause mortality, heart failurerelated hospitalization, and all-cause hospitalization (Inglis et al., 2015). Cost of use was
considered a secondary outcome.
Randomized controlled trials with interventions that included patient monitoring or selfcare management delivered via simple telephone technology were classified in the structured
telephone support group (Inglis et al., 2015).Noninvasive telemonitoring interventions included
the use of digital, broadband, satellite, wireless, or Bluetooth technologies via mobile phone and
personal digital assistant (PDA) applications. Structured telephone support decreased all-cause
mortality (RR = 0.87, 95% CI, 0.77-0.98), and heart failure-related hospitalization (RR = 0.85,
95% CI, 0.77-0.93) (Inglis et al., 2015). Likewise, noninvasive telemonitoring reduced all-cause
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mortality (RR = 0.80, 95% CI, 0.68-0.94) and heart failure-related hospitalization (RR = 0.71,
95% CI, 0.60-0.83) compared to usual care measures (Inglis et al., 2015). Neither intervention
demonstrated effectiveness in decreasing all-cause hospitalizations or costs associated with
chronic heart failure management (Inglis et al., 2015).
Kitsiou, Paré, and Janna (2015). Kitsiou, Paré, and Janna (2015) completed a Level I,
high-quality overview of systematic reviews and meta-level synthesis to evaluate the effect of
various forms of home telemonitoring measures on all-cause mortality and all-cause and heart
failure-related hospitalization. Fifteen systematic reviews that synthesized a total of 38 RCTs
and 67 observational studies, published between 2003 and 2013, were included in the review.
The telemonitoring interventions used in the RCTs included in the synthesis included: (a) videoconsultation, with or without the transmission of vitals, (b) mobile device telemonitoring, (c)
automated device-based telemonitoring, (d) interactive voice response, and (e) web-based
telemonitoring (Kitsiou et al., 2015). Of these interventions, only automated device-based
telemonitoring and mobile device telemonitoring were effective in decreasing participants’ risk
for heart failure-related hospitalization, with overall relative risk reduction ranging from 14% (HR
= 0.86, 95% CI, 0.61-1.21) to 36% (HR = 0.64, 95% CI, 0.34-1.14) (Kitsiou et al., 2015).
Interestingly, mobile phone application interventions decreased risk for hospitalization by 28%
(RR = 0.72, 95% CI, 0.42-1.26, p = 0.25); however, the sample size (4 RCTs and 1
observational study) was relatively small, leading to statistically insignificant results (Kitsiou et
al., 2015). As smartphone use continues to gain popularity, the use of the devices in chronic
condition management will presumably increase, and further large-scale studies will be needed
to investigate the role of this technology in practice.
Kotb, Cameron, Hsieh, and Wells (2015). Kotb, Cameron, Hsieh, and Wells (2015)
completed a Level I, high-quality, systematic review and network meta-analysis to determine the
effectiveness of telehealth strategies for patients who were recently discharged (<28 days) from
the hospital, following admission with a primary diagnosis of heart failure. Thirty RCTs, with a
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total of 10,193 patients, published between 1998 and 2012, were included in the review. Most of
the studies (27 out of 30) evaluated effectiveness of telehealth interventions for six months or
more.
Two primary interventions were detailed within the systematic review (SR). First,
structured telephone support delivered by a nurse was compared to usual care. Secondly,
telehealth interventions were evaluated; however, multiple telehealth modalities were lumped
into the same intervention category. Individual interventions were not separately studied;
therefore, direct conclusions about specific telehealth interventions were difficult to make. The
studies evaluated within the SR were chosen if they reported the following outcomes: mortality,
all-cause hospitalization, or heart failure-related hospitalization. Specifically, 16 RCTs evaluated
the outcome of heart failure-related hospitalization. Direct comparisons of the results of the
RCTs indicated that telemonitoring was more effective than usual care in reducing heart failurerelated hospitalization (OR = 0.64, 95% CI, 0.39-0.95) following recent (<28 days) hospital
discharge (Kotb et al., 2015). The researchers concluded that although both interventions
demonstrated positive outcomes, telemonitoring interventions were more effective than
structured telephone support at decreasing hospital readmission rates for patients with a recent
hospital discharge (Kotb et al., 2015). Further evaluation is needed to compare specific
telehealth interventions and the individual effects on heart failure-related hospitalization.
Bashi, Karunanithis, Fatehi, Ding, and Walters (2017). Bashi, Karunanithis, Fatehi,
Ding, and Walters (2017) synthesized the results of 19 systematic reviews, published between
2006 to 2015, to evaluate the effects of remote patient monitoring interventions on multiple
outcomes for patients who have heart failure. Remote patient monitoring (RPM) was defined as
“the use of devices to remotely collect and send patient data to a health care facility for
diagnostic interpretation or monitoring purpose” (Bashi et al., 2017, p. 2). The specific RPM
interventions used to monitor patient physiologic data and patient-reported symptom data,
detailed within the synthesis include: telemonitoring with the use of mobile phone applications,
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video monitoring, home telehealth, and electronic transfer of physiologic data from wearable
electronic devices or implantable devices (Bashi et al., 2017). Interestingly, although included in
many other synthesis reviews, structured telephone support interventions were not included
within this synthesis because the researchers determined that the intervention was largely
different from other methods of RPM (Bashi et al., 2017).
The goal of this evidence synthesis was to identify the RPM intervention that most
effectively improved clinical outcomes of patients with heart failure. Systematic reviews were
selected for inclusion if the evaluated outcomes could be classified into patient-oriented
outcomes or health service-oriented outcomes categories. Patient-oriented outcomes included
knowledge and self-care, health status, and well-being measures (Bashi et al., 2017). Healthservice outcomes included measures such as: rehospitalization, emergency department visits,
and hospital length of stay (Bashi et al., 2017). A total of six reviews show a reduction in heart
failure-related hospitalization. Overall, researchers indicated that RPM interventions are
beneficial in improving patient-specific clinical outcomes, such as a reduction in mortality; heart
failure-related hospitalization; and an improvement in quality of life. The researchers concluded
that the most important elements to include in RPM methods consist of the physiologic
monitoring of blood pressure, heart rate, weight, and electrocardiogram (ECG) data. Although
mobile phone-based monitoring systems are capable of collecting and transmitting this data,
based on this review, these interventions had insufficient evidence to determine effectiveness
on patient and health service-oriented outcomes, due to a small sample size (n=2). Rapid
advances in mobile phone technology and patient use of such devices indicates that further
research in this area is warranted. Thus, future use of these devices for heart failure
management can offer practical and affordable methods to improve patient and health service
outcomes (Bashi et al., 2017).
Lin, Yuan, Huang, Zhang, Mai, and Wang (2017). Lin, Yuan, Huang, Zhang, Mai, and
Wang (2017) completed a Level I, high-quality systematic review, composed of 39 well-
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designed RCTs, published between 1999 and 2013. The researchers wanted to thoroughly
evaluate the available evidence and provide an update on the effectiveness of telemedicine
interventions for treating patients with heart failure compared to standard care measures. There
was a considerable amount of heterogeneity in the design of the RCTs as well as the data
collected in each study. However, all RCTs incorporated telemedicine interventions that
involved telecommunication-based management of patients through nurse-driven telephone
support, patient self-report of physiologic data, or automated transmission of data from
implanted or wearable devices (Lin et al., 2017). The physiologic data transmitted varied from
study to study; however, most RCTs listed daily weight, blood pressure, heart rate, and
symptoms as requirements to be transmitted to the participants’ provider (Lin et al., 2017). The
data transmitted was reviewed by a heart failure nurse or advanced practice provider to
determine any abnormalities or the need for treatment adjustments (Lin et al., 2017). Changes
in treatment or recommendation for hospital readmission were made after consultation with the
cardiologist (Lin et al., 2017). The outcomes measured included all-cause hospital admission
rates, length of hospital stay, mortality, and heart failure-related hospitalization rates.
Twenty-nine studies reported heart failure-related hospital admission rates, including 18
telephone-supported intervention studies and 11 teletransmission studies (Lin et al., 2017).
Comparative analysis revealed that, compared to the control group, the overall telemedicine
group experienced significantly lower rates of heart failure-related hospital admission rates
(pooled OR = 0.63, 95% CI, 0.53-0.76, Z = -4.91, p<0.0001). Specifically, the telephone
supported group experienced a reduction in heart failure-related hospitalization rates (pooled
OR = 0.64, 95% CI, 0.52-0.79, Z = -4.15, p = <0.001) while the teletransmission group
experienced similar results (pooled OR = 0.61, 95% CI, 0.42-0.88, Z = -2.64, p = 0.008),
regardless of data transmission route (Lin et al., 2017). The authors concluded that patients who
have heart failure can benefit from the use of telemedicine interventions by increasing self-care
measures and seeking early intervention at the first sign of symptom exacerbation.
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Aronow and Shamliyan (2018). Aronow and Shamliyan (2018) conducted a Level I,
high-quality systematic review and meta-analysis that was comprised of two high-quality metaanalyses and 58 RCTs, published through March 2018. The systematic review examined the
effects of implementing noninvasive telemonitoring measures, or structured telephone support
programs in the management of adult heart failure patients, compared to usual care. Overall,
there was a significant amount of heterogeneity amongst the included studies. This was
evidenced by the lack of a consistent definition of noninvasive telemonitoring measures, the
inclusion of studies with interventions that utilized different devices for telemonitoring purposes,
and inconsistent reporting of study length and follow-up periods. The studies included in the
synthesis investigated the effects of noninvasive telemonitoring measures, structured telephone
support (STS) programs, or the combination of these interventions on heart failure chronic
management.
The outcomes of interest included: (a) all-cause mortality, (b) all-cause hospitalization,
and (c) heart failure-related hospitalization. Structured telephone support programs only had a
positive effect on the outcomes identified if the telephone calls were not prerecorded or overly
simplified (Aranow & Shamlivan, 2018). STS interventions that included direct clinical support by
health care professionals improved patient survival by decreasing all-cause mortality (RR =
0.86, 95% CI, 0.77 – 0.97). Similarly, the inclusion of simplistic telemonitoring systems did not
result in overt reductions in all-cause mortality; however, complex telemonitoring devices that
incorporated the transmission of daily physiologic data and subsequent analysis of data by a
healthcare professional were shown to decrease all-cause mortality (RR = 0.78, 95% CI, 0.620.99) in adult patients with chronic heart failure (Aranow & Shamlivan, 2018). Neither
noninvasive telemonitoring or structured telephone support programs had a statistically
significant effect on all-cause hospitalization (Aranow & Shamliyan, 2018). Lastly, heart failurerelated hospitalizations were decreased in studies with both STS (RR = 0.81, 95% CI, 0.710.94) and noninvasive telemonitoring measures (RR = 0.74, 95% CI, 0.62-0.88). Specifically,
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the inclusion of telemonitoring measures with the use of mobile phone and personal digital
assistance (PDA) devices decreased the patients’ risks for heart failure-related hospitalization
significantly (RR = 0.58, 95% CI, 0.44-0.77). Overall, the evidence supports the use of
noninvasive telemonitoring measures for patients with heart failure to prevent hospitalization.
Further studies are needed to determine the differences in effect between various types of
telemonitoring delivery or transmission systems.
Clark (2018). Clark (2018), completed a Level I, good-quality systematic review that
evaluated the effectiveness of incorporating telemedicine measures in the care of elderly
patients (≥70 years) who have heart failure. Forty-three moderate quality RCTs were included in
the systematic review; 23 (n = 9,332) of which were focused on STS programs, 18 (n = 3,860)
included noninvasive telemonitoring measures, and two remaining studies evaluated the
combination of STS programs and noninvasive telemonitoring interventions. The synthesis did
not include a detailed description of the interventions; however, regardless of the specific
intervention studied, the RCTs were similar in data collected. The interventions all included daily
transmission of physiologic data, such as: (a) electrocardiograph (ECG), (b) blood pressure, (c)
weight, (d) pulse, (e) oximetry, (f) respiratory rate, and (g) medication compliance (Clark, 2018).
The primary outcomes of interest were heart failure-related hospitalization, all-cause
hospitalization, and all-cause mortality.
Overall, noninvasive telemonitoring and STS interventions decreased heart failurerelated hospitalization (RR = 0.71, 95% CI, 0.60-0.83; RR = 0.85, 95% CI, 0.77-0.93,
respectively) and all-cause mortality (RR = 0.80, 95% CI, 0.68-0.94; RR = 0.87, 95% CI, 0.770.98, respectively). Neither intervention group demonstrated the ability to decrease all-cause
hospitalization rates. This SR was particularly interesting because there is a generalized belief
that elderly patients are incapable of using, and thus, benefitting from telemedicine
interventions. Technology continues to rapidly advance, and although the aging population may
not be the target audience or consumer group, it does not mean that these advanced methods
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of daily monitoring cannot be used within this patient population. The evidence supports
including noninvasive telemonitoring measures and STS programs in the management of
elderly patients who have heart failure.
Hamilton, Mill, Birch, and Thompson (2018). Hamilton, Mill, Birch, and Thompson
(2018) completed a smaller scale, Level I, high-quality systematic review comprised of five
RCTs and four feasibility studies that evaluated the effect of utilizing mobile health (mHealth)
technology in the management of cardiovascular disease. Three RCTs and one feasibility study
were specific to heart failure. The interventions studied within this SR differed slightly from those
discussed previously. A subset of telehealth, known as mHealth, “broadly refers to medical and
public health practice supported by mobile devices that include mobile phones, smartphones,
PDAs, and other patient monitoring devices” (Hamilton, Mill, Birch, & Thompson, 2018, p. 2).
Secondary to the widespread assimilation of smart devices into everyday life, researchers
postulated that implementing daily monitoring programs into these platforms could benefit
patients with chronic conditions that require frequent monitoring and treatment modification,
such as heart failure. Two primary interventional approaches were identified. The first
intervention included mHealth as an adjunct treatment to usual care measures. The second
intervention type was the independent use of mHealth methods compared to usual care
measures. All RCTs incorporated the use of smartphone surveillance systems to monitor patient
status daily. Participants were tasked with collecting physiological data, such as weight, blood
pressure, symptoms, and medication adherence, and then entering the data into the
smartphone application for review by a study physician. Finally, if data entered was outside of a
pryori datasets, an email alert was sent to the study physician for prompt review. The primary
outcome was rehospitalization for worsening heart failure. Secondary outcomes included patient
adherence and ease of use.
Overall, mHealth was found to be comparable to traditional heart failure treatment
methods. There was a statistically significant 54% relative risk reduction in hospitalization for the
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mHealth group compared to the control group after 6 months of intervention (RRR = 50%,
p=0.06). Study participants demonstrated high levels of adherence (78%-91%) and daily
utilization (90%) of the mHealth platform. Several participants (n=17) continued to use the
smartphone platform after the study had ended, indicating high acceptability of the intervention.
The use of smart devices in mHealth heart failure management programs has the potential to
decrease health care utilization by decreasing hospitalization and readmission rates. There is a
relatively small amount of studies focused on this subset of telehealth due to the recent nuances
of technology. Further research should be conducted to determine large scale effectiveness
participant acceptability.
Pekmezaris et al., (2018). Pekmezaris et al., (2018) conducted a Level I, high-quality,
systematic review with meta-analysis that was comprised of 26 RCTs (N = 2,506), published
between 2001 and 2016. The SR was one of the first to not only evaluate the effect of telehealth
interventions for patients who have heart failure, but also to evaluate the impact of the duration
of monitoring with telehealth modalities. The primary outcomes were all-cause mortality, heart
failure-related mortality and hospital utilization. Interventions evaluated in the RCTs included
telehealth communication modalities such as telephone programs, smart phone applications,
email, text messaging, and web-based platforms.
Twelve studies reported all-cause mortality at 180-days and at 365-days. At 180 days,
telemonitoring interventions were associated with a 40% decrease in the odds of all-cause
mortality (OR = 0.60, 95% CI). However, the effect was not significant at 365 days (OR = 0.85,
95% CI, p = 0.461). Only two studies reported heart failure-related mortality. At 180 days,
telemonitoring interventions were associated with a 61% decrease in odds of mortality (OR =
0.39, 95% CI); however, this was a very small sample size, yielding the results difficult to
generalize to a larger population.
Hospitalization was an outcome reported by seven RCTs, data was provided at 90 days
and at 180 days after implementation of telemonitoring interventions. Telemonitoring was not
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shown to be effective at decreasing all-cause hospitalization at 90 days (OR = 0.81, 95% CI, p =
0.472) or 180 days (OR = 0.97, 95% CI, p = 0.902). Five RCTs reported heart failure-related
hospitalization at 180 post-implementation of telemonitoring intervention. The telemonitoring
modalities evaluated were not associated with decreased hospital utilization (OR = 0.69, 95%
CI, p = 0.112). This finding was in opposition to the initial prediction from study researchers.
Researchers indicated that the effectiveness of telemonitoring interventions is time
dependent. The under effectiveness of interventions is likely to be secondary to disease
progression and intervention adherence decline. Keeping patients involved in telemonitoring
programs is essential to the success of the programs. Further research is warranted to
determine how to keep participants motivated and willing to utilize telemonitoring interventions.
Level II Evidence
Cajita, Gleason, & Han (2016). Cajita, Gleason, and Han (2016) conducted a Level II,
high-quality systematic review (N=1,777) comprised of six RCTs and four quasi-experimental
studies published between 2006 and 2015. The objective of the SR was to identify currently
available mobile health (mHealth) interventions and to determine the effect of those
interventions on heart failure outcomes such as all-cause and heart failure-related mortality, and
heart failure-related hospitalization. Secondary outcomes included hospital length of stay, New
York Heart Association (NYHA) heart failure classification, left ventricular ejection fraction,
quality of life, and participant self-care management. The small sample size of studies ranged in
duration from four weeks to 24 months. The telemonitoring devices evaluated within the studies
included mobile smart devices, wireless data receivers, ECG recorders, implantable
defibrillators, and smart phone applications. Regardless of the device used, most of the studies
evaluated required the transmission of daily data that included weight, blood pressure, and ECG
recordings to a central monitoring center or designated provider. Overall, the SR results were
inconclusive, with none of the identified interventions having a statistically significant positive
effect on the observed outcomes. Specifically, there was no observable difference between
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groups regarding all-cause or heart failure-related mortality or hospitalization. These findings
could be due to the limitations of the study. The small sample size, intervention heterogeneity,
and inclusion of quasi-experimental studies limits the credibility and generalizability of study
findings. Further research is warranted to study the value of including continually advancing
telemonitoring devices in the care of patients who have heart failure.
Rosen, McCall, & Primack (2017). Rosen, McCall, and Primack (2017) conducted a
Level II, good-quality RCT to evaluate adherence to- and effectiveness- of a telehealth protocol
designed to reduce heart failure-related hospitalization. Researchers developed a telehealth
platform that incorporated daily real-time reporting of health status and video conferencing
capabilities. Potential participants were identified through insurance claims data provided by a
regional managed care organization. Patients were eligible for participation if he/she had a
diagnosis of heart failure and at least one emergency room visit or hospitalization within the last
three years. A random sample of the eligible participants received a recruitment letter detailing
the study objectives. A total of 50 adult patients who had heart failure were enrolled.
Study participants were provided with a smart device enabled with the telehealth
application and video conferencing platforms, as well as a blue-toothed enabled scale. The
smart device program including daily educational sessions to enforce the importance of selfcare in chronic heart failure management. Patients were encouraged to report weight and
relevant symptoms experienced, such as shortness of breath, difficulty performing daily
activities, and medication compliance. The information uploaded by the participants was
automatically routed to social workers who were trained as heart failure coaches. In addition to
daily review of patient data, the social workers conducted weekly video sessions that were
designed to educate patients about self-care measures and behavior change. Study duration
was six months.
The primary outcomes of interest included patient adherence to the program and heart
failure-related admissions and readmissions. Secondary outcomes included all-cause admission
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and readmission. Researchers evaluated adherence by conducting Mann-Whitney U tests, due
to the abnormal distribution of the ordinal data collected. Binomial tests were conducted to
determine the differences in admissions and readmissions when comparing post-intervention
data to data retrieved from the control period, six-months prior to study enrollment.
Participant study adherence was high. The researchers reported a 96% adherence rate
for the 48 participants who completed the study. Also, admission and readmission rates, both
all-cause and heart failure-related, were decreased significantly in the intervention period
compared to the control period. During the six-month intervention period, there were 53% (p =
.007) fewer heart failure-related admissions, 83% (p = .01) fewer heart failure-related
readmissions, 25% (p = .01) fewer all-cause admissions, and 57% (p = .006) fewer all-cause
readmissions. The study findings are promising; however, larger rigorously-designed
comparison trials are required to determine generalizability of findings.
Frederix et al., (2019). Frederix et al., 2019 conducted a long-term follow-up study to
determine the effectiveness of an initial six-month telemonitoring program compared with usual
care. The large, multicenter, Telemonitoring in the Management of Heart Failure (TEMA-HF) I
RCT (Dendale et al., 2011) was conducted to determine if telemonitoring platforms were
effective at increasing collaboration between general practitioners and heart failure providers, in
order to reduce mortality, and hospital utilization. The RCT included 160 participants who were
randomly assigned to a telemonitoring intervention group or usual care group. The
telemonitoring group was encouraged to measure and input weight, blood pressure, heart rate,
and symptoms daily into an electronic device that transmitted data to an online database. If
predetermined limits for the data were exceeded, an email was automatically sent to the
participants’ general practitioner and the heart failure clinic providers to determine if intervention
was required to prevent exacerbation. The initial study duration was six months. Study
outcomes indicated that the telemonitoring intervention had the potential to reduce all-cause
mortality and heart failure-related hospitalization.
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This study was a long-term follow-up study to assess whether the initial six-month
intervention implemented during the TEMA-HF I study would result in decreased all-cause
mortality, heart failure-related hospitalization, and healthcare costs compared to usual care.
This study was completed 6.5 years after the initial study was conducted. At the completion of
the “no-telemonitoring” period, 142 initial study participants were alive and included in the longterm follow-up study, which aimed to evaluate the same primary outcomes as the initial TEMAHF I study. Ultimately, all-cause mortality was not significantly different between the
telemonitoring and control groups. However, number of days lost due to heart failure
readmission (U = 2640, z = -2.04, p = 0.04) was significantly lower in the telemonitoring group
(7.28 ±12.55 days) compared to the usual care group (11.81±18.57 days). Patients older than
75 years of age in the telemonitoring group were readmitted to the hospital less frequently than
participants in the control group (U = 905, z = -2.27, p = 0.026). Although the initial intervention
did not appear to have a positive effect on overall mortality, patients in the intervention group
experienced a reduced risk for hospital readmission in the initial six-month study period with an
extended protected effect at 6.5 years follow-up. The reason for the sustained benefit is largely
unknown, thus further research is warranted.
Level III Evidence
Long, Babbitt, Cohn (2017). Long, Babbitt, and Cohn (2017) conducted a small-scale,
Level III, good-quality systematic review (SR), comprised of six studies (N = 51,014) published
between 2011 and 2016. The primary objective of the SR was to evaluate the effectiveness of
home telemonitoring use on 30-day hospital readmission rates of patients who have a diagnosis
of heart failure. Two randomized prospective-design studies, one quasi-experimental
prospective design study, two retrospective analysis studies, and one observational study were
included within the systematic review. All of the included studies identified usual post-discharge
care as the control variable and various home telemonitoring programs as the intervention
variable. The telemonitoring groups had heterogeneous interventions; however, all included
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daily monitoring of patient weight, blood pressure, heart rate, and heart failure exacerbation
symptoms. There was no statistically significant reduction in 30-day readmissions in the
intervention group compared to the control group. The authors noted that the small sample size
and lack of consistency between telemonitoring interventions as a possible explanation for this
finding. Thus, further large scale, rigorously designed studies are required to determine the
effectiveness of telemonitoring interventions.
Dadosky, Overbeck, Barbetta, Bertke, Corl, Daly, Hilees, Rector, Chung, & Menon
(2018). Dadosky et al. (2018) conducted a prospective, nonrandomized trial to evaluate the
effect of telemanagement of heart failure patients on hospital readmission rates and patient selfcare knowledge and satisfaction. Forty-six adults who had stage IV heart failure were identified
by the heart failure team upon hospital admission and were subsequently recruited to participate
in the study. The comparison group was comprised of 96 historical patients who received
standard heart failure care.
Participants in the intervention group received daily telemanagement care at a skilled
nursing facility (SNF) for up to 30 days. Participants were fitted with a wearable, nonimplanted
telemonitoring device that continuously measured heart rate, respirations, body position and
single-lead ECG. In addition to the data collected from the wearable device, Bluetooth pulse
oximeters, blood pressure cuffs, and weight scales were also utilized daily. The nursing staff at
the SNF also performed point-of-care lab testing to evaluate B-type natriuretic peptide (BtNP)
and basic metabolic panels, along with Bluetooth equipped stethoscopes to assist with remote
patient assessments. Live participant data was uploaded daily to a central dashboard, visible by
both SNF staff and program clinicians. If a patient was out of the normal data range, interactive
telemanagement video sessions were facilitated by SNF staff. Clinicians were able to review
uploaded participant data and complete virtual patient assessments with the assistance of the
SNF staff and Bluetooth-enabled equipment. This process allowed for prompt exacerbation
intervention via treatment adjustment, or recommendation for emergency room visit.
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Following the telemanagement program implementation, there were statistically
significant reductions in the amount of time to intervention, compared to standard care methods.
Clinicians were contacted when participants’ data were outside of predefined limits and prompt
treatment adjustments were made to prevent further symptom exacerbation. Time lapsed prior
to medication adjustment decreased from a usual care average of 1,080 minutes to six minutes
for angiotensin converting enzyme inhibitors (ACE-I); 5,760 minutes to five minutes for beta
blockers, and 3,641 minutes to five minutes for diuretics. Participants were also referred to the
emergency room sooner in the course of exacerbation, decreasing from an average of 84
minutes to 15 minutes. Owing in large part to the prompt intervention time, the telemanagement
group experienced a 27.24% relative risk reduction in 30-day readmission rates (n = 8, 17.9%)
compared to the comparison group (n = 22, 23.9%) despite having a higher CORE 30-day
readmission rate prediction risk (29.4 ± 5.1 and 23.9 ± 5.1, respectively). This data indicates
that telemanagement can be used to achieve reduced readmission rates even in high-risk
patient populations.
Level VII Evidence
Schwamm et al., (2016). Although the final piece of evidence is lowest on the evidence
hierarchy, (O’Mathúna & Fineout-Overholt, 2019) it was selected for inclusion in this EBP
project because it is a policy statement from the American Heart Association (AHA) that
summarizes the use of telehealth interventions in cardiovascular and stroke care. The AHA
commissioned a task force of experts in cardiovascular and stroke management (Schwamm et
al., 2019) to evaluate the available evidence and to compose a policy statement about the use
of telehealth interventions in this patient population. The task force evaluated current telehealth
interventions that have been shown to increase patient access to care or enhance quality of
care; current barriers to telehealth program implementation; financial components, such as cost
of program set up and annual maintenance costs; legal and regulatory barriers; and emerging
telehealth platforms that could potentially resolve current program limitations.
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The task force identified mobile device-based telehealth platforms, such as smartphone
applications, as an emerging healthcare delivery modality that can increase patient engagement
and strengthen the relationship between the patient and provider. The task force also
acknowledged that telehealth platforms have the potential to transform the patient and provider
interaction and enable prompt point-of-care decision making in the event of condition
exacerbation or deterioration, leading to earlier intervention and decreased need for
hospitalization. Unfortunately, when this policy statement was written in 2016, there were many
regulatory barriers in effect that limited reimbursement for telehealth interventions. Additionally,
the task force determined that there was insufficient data available to determine cost
effectiveness of telehealth programs. Ultimately, while acknowledging the potential benefit of
using telehealth platforms in the care of patients with cardiovascular and stroke conditions, the
task force identified a larger need for more research to enable a thorough evaluation of the
rapidly advancing telehealth subspecialty.
Construction of Evidence-based Practice
Synthesis of Critically Appraised Literature
Applying the steps of the Iowa Model-Revised, an opportunity for improvement in the
prevention of hospitalization and hospital readmission for patients who have heart failure was
identified. The topic became a priority following the passage of the Affordable Care Act (ACA),
as hospital organizations are now penalized a portion of Medicare reimbursement dollars if
readmission rates are higher than expected values (CMS, 2020c). After many failed initiatives to
decrease heart failure readmission and subsequent skyrocketing health care costs, there
remains a desperate need to identify an intervention that can effectively manage patients’ heart
failure status daily and prevent hospital readmissions.
Following an exhaustive literature search process, synthesis of the 16 chosen pieces of
evidence was undertaken. Similarities and differences across the evidence were recognized
and major trends were elicited. Although there were inconsistencies across the evidence,
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telehealth interventions were identified as continually emerging heart failure management
options.
The depth of evidence supporting this intervention was significant. Many large scale,
Level I pieces of evidence were identified. Specifically, the search completed within the JBI
database revealed one recommended practice summary (JBI, 2019) and three evidence
summaries (Li, 2018; James & Hons, 2019; Moola, 2018) that recommended (Grade A) the use
of telehealth patient monitoring modalities in the care of patients who have heart failure. Multiple
sources of evidence have shown that when added to usual care measures, the use of telehealth
platforms can reduce heart failure outcomes, such as hospitalization, in a cost-effective way
(Kitsiou et al., 2015; Kotb et al., 2015; Bashi et al., 2017; Lin et al., 2017; Aronow & Shamliyan,
2018; Clark, 2018; Hamilton et al., 2018; Rosen et al., 2017; Frederix et al., 2019; & Dadosky et
al., 2018).
Telehealth Interventions
When undertaking synthesis of the sources of evidence, it was noted that “telehealth”
has many definitions and is frequently used as an umbrella term that encompasses various
telecommunication intervention platforms. Terms such as telemedicine, telemonitoring, mobile
health (mHealth), and telecommunication are used interchangeably within the literature. For the
purposes of this EBP project report, the various terms will be encompassed by and referred to
as “telehealth.”
Three main subsets of telehealth were extensively studied within the available literature,
structured telephone support (STS) programs (Clark, 2018; Inglis et al., 2015; Kotb et al., 2015;
Lin et al., 2017; Aronow & Shamliyan, 2018), noninvasive remote telemonitoring (Flogren et al.,
2015; Inglis et al., 2015; Lin et al., 2017; Clark, 2018; Bashi et al., 2017; Kitsiou, Parré & Jaana,
2015; Hamilton et al., 2018; Rosen et al., 2017; Frederix et al., 2019; Dadosky et al., 2018), and
implantable telemonitoring. Due to the time and financial limitations of this EBP project,
implantable telemonitoring devices were not included in the evidence synthesis. The remaining
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interventions identified within the evidence, structured telephone support programs and
noninvasive telemonitoring, were largely heterogenous, which limited the ability to conduct
meta-analyses. However, despite the specific telehealth platform used, the majority of
interventions required the daily transmission of patient specific physiologic data such as weight,
blood pressure, heart rate, and symptom status (Inglis et al., 2015; Kitsiou et al., 2015; Kotb et
al., 2015; Bashi et al., 2017; Lin et al., 2017; Aronow & Shamliyan, 2018; Clark, 2018; Hamilton
et al., 2018; Pekmezaris et al., 2018; Cajita et al., 2016; Rosen et al., 2017; Frederix et al.,
2019; Long, Babbitt, & Cohn, 2017; Dadosky et al., 2018). Evidence suggests that when used
appropriately, telehealth interventions can be as effective as face-to-face management for
patients who have heart failure (Flodgren et al., 2015; Inglis et al., 2015).
Structured Telephone Support (STS). Within the sources of evidence examined,
structured telephone support involved patient monitoring or self-care management delivered
using simple telephone technology (Inglis et al., 2015; Clark, 2018). Although study
interventions were heterogenous, the most effective programs were those led by specially
trained health care workers, such as nurses or social workers. There was no benefit over usual
care measures if the telephone intervention was prerecorded, solely educational-focused or
overly simplified. Although STS interventions were capable of decreasing important heart
failure-related outcomes, such as mortality (Inglis et al., 2015; Lin et al., 2017; Kotb et al., 2015)
and hospitalization (Inglis et al., 2015; Lin et al., 2017; Kotb et al., 2015), compared to
noninvasive remote telemonitoring interventions, STS programs were labor intensive, requiring
dedicated staff and long hours of operation (Inglis et al., 2015; Aronow & Shamliyan, 2018). In
addition, STS interventions were not found to be cost effective (Inglis et al., 2015).
Noninvasive Remote Telemonitoring. Noninvasive remote telemonitoring involves
either the continuous or intermittent transmission of daily patient data through the use of various
devices, such as smartphones, personal computers, and PDAs (Inglis et al., 2015; Cajita et al.,
2016; Hamilton et al., 2018; Pekmezaris et al., 2018). The success of such interventions is
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largely dependent on patient ability to operate the device (Schwamm et al., 2016) and
adherence to the program (Rosen et al., 2017). Technology continues to advance rapidly, and
with continued use, evaluation of successes and failures, and program revision, noninvasive
remote telemonitoring programs have the potential to play a dominant role in chronic heart
failure management.
Mobile Health Applications (MHA). Mobile health applications are a subcategory of
noninvasive remote telemonitoring programs that utilize smartphone technology. Over the
course of the last two decades, smartphones have been steadily assimilated into American
culture. Interestingly, 81% of Americans own a smartphone, with essentially equal distributions
across age strata (Pew Research Center, 2019). Thus, the use of smartphone technology has
the potential to reach substantial volumes of patients and play a large role in chronic disease
management (Pew Research Center, 2019). Although this use of smartphones is relatively new,
recent studies indicate that smartphone MHAs are effective in decreasing heart failure-related
outcomes such as, mortality (Hamilton et al., 2018) and hospitalization (Kitsiou et al., 2018;
Hamilton et al., 2018) or hospital readmission (Hamilton et al., 2018; Frederix et al., 2019), with
reportedly high levels of acceptability and program adherence (Hamilton et al., 2018; Rosen et
al., 2017).
Outcomes
Several heart failure related outcomes including hospitalization or hospital readmission
(Flodgren et al., 2015; Inglis et al., 2015; Kitsiou et al., 2015; Kotb et al., 2015; Bashi et al.,
2017; Lin et al., 2017; Aronow & Shamliyan, 2018: Clark, 2018; Hamilton et al., 2018;
Pekmezaris et al., 2018; Cajita et al., 2016; Rosen et al., 2017; Frederix et al., 2019; Long et al.,
2017; Dadosky et al., 2018), mortality (Inglis et al., 2015; Kotb et al., 2015), self-care
management (JBI, 2019; Lin et al., 2017; Cajita et al., 2016), hospital length of stay (Clark,
2018; Cajita et al., 2016), cost effectiveness (Flodgren et al., 2015; Inglis et al., 2015), quality of
life (Flodgren et al., 2015; Cajita et al., 2016), left ventricular ejection fraction (Cajita et al.,
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2016), and NYHA class (Cajita et al., 2016) were studied. The focus of this EBP project was
decreasing hospitalization and 30-day hospital readmission rates for patients who have heart
failure.
Hospitalization Rates and Readmission Rates. Upon review of the evidence,
considerable variability was observed among the studies. For example, there were extensive
inconsistencies in the measurement of time between hospitalization and hospital readmission
rates among the studies included in this review. The time frames for data reevaluation ranged
from less than 30 days (Long et al., 2017; Dadosky et al., 2018; Hamilton et al., 2018) to 365
days (Flodgren et al., 2015; Pekmezaris et al., 2018), one study evaluated the “days lost to
readmission” 6.5 years after the initial telehealth intervention was implemented (Frederix et al.,
2019). These findings indicated the need for future research to be streamlined and rigorously
designed so that direct comparisons were easier to make.
Despite the inconsistencies, many studies that employed some type of telehealth
intervention identified positive reductions in heart failure-related hospitalization (Flodgren et al.,
2015; Inglis et al., 2015; Kitsiou et al., 2015; Kotb et al., 2015; Lin et al., 2017; Aronow &
Shamliyan, 2018; Clark, 2018; Hamilton et al., 2018; Rosen et al., 2017; Frederix et al., 2019;
Dadosky et al., 2018). There were limited research studies that evaluated the outcome of 30day readmissions. Current research is heavily focused on the broader topic of hospitalization or
rehospitalization, with varying lengths of time to evaluation periods. Only two studies (Long et
al., 2017; Dadosky et al., 2018) evaluated 30-day readmission rates independent of overall
hospitalization, with inconclusive results, each citing substantial study limitations. Although data
indicate that telehealth interventions can be effective in decreasing hospitalization, the
heterogeneity of available heart failure-related research made it difficult to draw generalizable
conclusions that were specific to the outcome of 30-day readmission rates.
In summary, after completion of the comprehensive literature search and synthesis of
evidence, it is evident that telehealth interventions, including mobile health applications are
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continually emerging technology systems that have the potential to positively influence heart
failure outcomes. Mobile health applications have been shown to decrease heart failure-related
mortality (Hamilton et al., 2018) and hospitalization (Kitsiou et al., 2018; Hamilton et al., 2018) or
hospital readmission rates (Hamilton et al., 2018; Frederix et al., 2019).
Best Practice Model Recommendation
Several interventions that incorporated telehealth modalities were examined during the
literature review. The available evidence supports the use of telehealth platforms in the
management of chronic health conditions. More specifically, the best practice model
recommendation for heart failure rehospitalization prevention includes the addition of telehealth
platforms, such as noninvasive remote monitoring with MHAs, to usual care standards
(Flodgren et al., 2015; Inglis, et al., 2015; Lin et al., 2017; Aronow & Shamliyan, 2018; Clark,
2018; Hamilton et al., 2018; Rosen et al., 2017; Frederix et al., 2019; Dadosky et al., 2018).
The comprehensive literature review helped to answer the following question proposed
by the EBP project leader: What is the most accessible, feasible, sustainable, and cost-effective
strategy that can be utilized in the outpatient setting to decrease hospital readmission related to
heart failure in this practice setting? Synthesis of the evidence obtained through the literature
search indicate that the implementation of a MHA program, designed to thwart heart failure
exacerbation and prevent the need for hospitalization or readmission, to be the most
appropriate intervention.
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CHAPTER 3
IMPLEMENTATION OF PRACTICE CHANGE
This EBP project was designed to evaluate the effectiveness of a patient-guided heart
failure MHA on individual and organizational 30-day readmission rates. A secondary purpose of
this EBP project was to determine if the utilization of the MHA increased patient self-care
practices. By encouraging daily patient participation, through the use of the MHA, the patient
became an active member of the healthcare team. MHAs have been used as a selfmanagement tool to increase patient self-care practices (James, 2019; Lin et al., 2017; Cajita et
al., 2016; Schwamm et al., 2017), increase communication with providers (Long, Babbitt, &
Cohn, 2017; Dadosky et al., 2018), and allow for disease status evaluation and prompt
intervention, (Dadosky et al., 2018; Schwamm et al., 2017) if necessary. This project was of
particular importance because healthcare systems are becoming increasingly dependent on
telehealth platforms, secondary to the COVID-19 pandemic. Heart failure management requires
daily monitoring of symptoms and frequent intervention to maintain homeostasis and prevent
exacerbation. Thus, a MHA intervention to improve daily heart failure management was
implemented. After permission to use the HFPath® MHA was granted by the AHA (Appendix C),
thirty-day readmission rate outcomes were evaluated pre-intervention, at 30-days post
hospitalization, and again at 8-weeks post-intervention to determine if the intervention was
effective.
Participants and Setting
This EBP project was implemented at a small, rural, 129-bed Northwest Indiana hospital.
This hospital is one of only two hospitals in the county and draws patients from three
surrounding Indiana counties. The hospital is owned and operated by a national organization of
for-profit hospitals. Census varied widely, but generally ranged from 80-90 inpatients per day (R.
Flinchum, personal communication, September 9, 2020). The reduction of heart failure 30-day
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readmissions has become a significant focus of the organization. In 2018, the CMS calculated
expected 30-day heart failure readmission rate was 21.4 patients (CMS, 2020d). The
organization’s true heart failure readmission rate for 2018 was well above the expected rate,
with 64 readmissions (CMS. 2020d), prompting a large Medicare reimbursement reduction
(Russell, 2018).
Project participants consisted of heart failure patients who had a recent inpatient
admission at this facility. Heart failure admission data were obtained, and potential participants
were identified through a chart review process. Individuals who met inclusion criteria were:
Adults, 18 years and older; English-speaking; Medicare beneficiaries; and smart device owners,
who had a recent inpatient admission with a primary diagnosis of heart failure (not stage
dependent). Individuals less than 18 years of age, pregnant women, nursing home residents,
and those who did not own or have access to a smart device were excluded from project
participation. The majority of participants were recruited from the inpatient setting, however, a
provider information document (Appendix D) was circulated to the organization’s cardiologists in
effort to gain additional prospective participants.
Pre-Intervention Group Characteristics
Following identification of prospective participants, brief individual education sessions
were provided by the project leader to explain the EBP project and demonstrate the use of the
MHA. Potential participants were given a packet of information that further detailed project
objectives. Project leader contact information was also provided within the educational packet.
Potential participants were encouraged to reach out to the project leader with any questions or
concerns. Phone numbers were collected for patients who were interested in participating.
Patients who declined participation comprised the comparison group. Following hospital
discharge, the project leader contacted the prospective participants, via telephone, to gather
demographic data and complete the pre-intervention European Heart Failure Self-Care
Behavior Scale (EHFScBS) (Jaarsma, 1999) (See Appendix E). Permission to use the
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EHFScBS within this EBP project was granted by the creator of the scale, T. Jaarsma
(Appendix F). Demographic data including age, sex, race, ethnicity, education level, heart
failure classification, admission history, and smart device ownership were collected and
evaluated (See Appendix G). The data collected was utilized following project completion to
determine generalizability of findings. A sample size of 25 patients, comprising the intervention
and comparison groups, was targeted to determine clinical significance of the project.
Ultimately, nine individuals agreed to participate in the project, eight of whom completed project
requirements.
Intervention
The intervention consisted of daily participant use of a heart failure MHA designed to
improve self-care behaviors and decrease the risk for hospital readmission. The American Heart
Association (AHA), a trusted organization involved intensely in heart failure management
guideline development, has produced a MHA entitled, HFPath® (AHA, 2020). This MHA was
chosen for project use because it correlated with the Rise Above Heart Failure® and Get with
the Guidelines ® initiatives published by the AHA (2017). This patient-initiated MHA is available
free-of-charge and is downloadable through the iOS AppStore®, GooglePlay®, and
HFPath®Online. The HFPath® MHA includes features such as patient education provided by
the AHA, as well as symptom, weight, and blood pressure trackers, that participants were asked
to collect and input data for each day. The data were not automatically uploaded to a central
monitor or to a specific provider; therefore, the MHA offered indicators that notified the
participant when provider notification or emergent care was recommended.
Following input of daily physiologic and symptom data, the MHA generated a colorcoded zone that indicated the participants’ disease status (AHA, 2020). The green zone
indicator was the daily goal. In this zone, the participants’ symptoms were under control with no
overt indication of symptom exacerbation. The yellow zone was a warning indicator. If the
participant experienced any of the following symptoms: Weight gain greater than 2 pounds (lbs.)
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overnight or 3 to 5 lbs. in a week; new or more frequent chest pain or tightness; increased
shortness of breath; increased edema to the lower extremities; dizziness; falls; fatigue; dry,
hacky cough; or general unrest, a call to the provider was then warranted. The red zone served
as an emergency indicator. Participants were instructed to call 911 or to go to the nearest
emergency room if any of the following symptoms were present: Unrelenting chest pain, severe
shortness of breath, or new onset confusion. The MHA was used as a self-monitoring tool to
improve participant self-care measures and medication adherence, and to identify early
symptoms of exacerbation, which allowed for prompt provider communication and treatment
adjustment prior HF decompensation (AHA, 2020).
The project leader called each intervention group participant every week, at
predetermined times (See Appendix H) to evaluate appropriate use of the MHA and to
determine whether the participant received any warning indicators that prompted provider
contact or emergency room visits. Due to the nature of the disease, heart failure patients were
identified and recruited for project participation at varying times, which required a rolling project
schedule. Therefore, an individualized project schedule was established for each participant. All
participants were in the same cohort for evaluation purposes but had differing project start and
end dates. Participant readmission data were evaluated 30-days and 8-weeks following
intervention initiation. Participant report of admission to project leader, hospital census data, and
chart reviews were analyzed to determine readmission frequency for the intervention group.
Readmission occurrence for the members of the control group were evaluated by monitoring
patient census data and by conducting chart reviews. Following project completion, a final
phone meeting took place between the project leader and individual participants. At this time,
the number of hospitalizations and readmissions were assessed. At project completion, a postintervention EHFScBS (See Appendix E) and participant satisfaction survey (See Appendix I)
were conducted with members of the intervention group.
Comparison
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Higher than anticipated rates of heart failure-related 30-day readmissions and financial
retribution were the impetus for this EBP project. MHAs have emerged as an effective tool for
decreasing hospital readmissions. Retrospective chart reviews were conducted to evaluate preintervention heart failure-specific hospital admission rates for members of the intervention and
comparison groups. The time period of interest spanned up to three months prior to project
commencement. This provided baseline data for comparison with subsequent evaluation
periods occurring at 30-days and 8-weeks post-intervention.
Outcomes
The primary outcome of interest was heart failure-related 30-day readmission rates.
Prior to initiation of the intervention, participant admission history was reviewed to determine
number of hospitalizations within the previous three months. Readmission data were assessed
in the same manner following 30-day and 8-week post-intervention time frames. There were two
post-intervention points of data collection for individual readmission rates within each project
group. Therefore, a multivariate analysis of variance (MANOVA) statistical test was conducted
for each measure, to determine the significance of the intervention. Secondly, because the goal
of this project was to evaluate potential associations between the use of the MHA and reduction
in risk of readmission, epidemiology measures of association (OR, ARR, NNT) were calculated
for the intervention group. Organizational readmission rate data were provided by the quality
assurance manager, rates were compared pre- and post-intervention.
The secondary outcomes of interest were patient participation in self-care behaviors and
overall satisfaction with the use of the MHA. Self-care behaviors were evaluated by completing
the EHFScBS prior to intervention implementation and again following the 8-week intervention
period. The EHFScBS has been evaluated to determine psychometric quality and
appropriateness of use. The scale has been shown to be internally consistent, valid, and reliable
with good test-retest reliability (Jaarsma et al., 2008). The EHFScBS evaluated participantreported participation in self-care activities recommended for individuals who have heart failure.
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Responses to self-care participation prompts, were provided on a five-point Likert scale that
evaluated the participants’ degree of agreement with each statement. Responses ranged from “I
completely agree” to “I do not agree at all.” Post intervention EHFScBS results were compared
to the pre-intervention results to evaluate the effect of the intervention. The paired sample t-test
was used to evaluate the difference of pre- and post-intervention participation in self-care
behaviors.
Lastly, participant satisfaction related to the use of the MHA was evaluated with the use
of a project leader-created five-point Likert-scale satisfaction survey. Participants rated project
satisfaction by indicating level of agreement with each item on the survey. Responses ranged
from “I completely agree” to “I do not agree at all.” A meaningful number (1-5) corresponded
with each level of response. The average overall survey score was calculated, and a single
sample t-test was conducted to determine overall level of project satisfaction.
Time
The projected timeline for this project extended from September 2020 through midJanuary 2021. Prior to commencing the intervention, informational meetings were held with key
stakeholders, including the HF liaison, the transitional care team, and members of the quality
assurance department. After establishing project importance, and receiving positive feedback
from stakeholders, a project plan and timeline were developed. Due to time constraints imposed
by the university calendar, an eight-week intervention period was determined to be appropriate.
The nature of the illness necessitated some timeline flexibility. Participants experienced project
implementation at varying times, dependent on time of hospitalization. This demonstrated the
need for a staggered project implementation phase and a rolling 8-week calendar. To ensure
that each patient received a full eight weeks of MHA use, the deadline for final participant
enrollment was November 1, 2020. All participants completed the project intervention phase by
December 27, 2020. Post-intervention EHFScBS were completed via telephone after the 8week intervention phase. Although intervention period completion occurred at varying times for
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each participant, all post-intervention EHFScBS evaluation and participant satisfaction surveys
were conducted prior to December 31, 2020. Within this organization, 30-day readmission rates
are reported with a three-week delay. Therefore, final data collection was completed January
17, 2021.
Protection of Human Subjects
As with any method of research or EBP project utilization, participant protection was of
utmost importance. Every step of the project was meticulously planned and designed to provide
fair treatment to all participants without the use of coercion or manipulation. The project leader
completed the Collaborative Institutional Training Initiative (CITI) program on April 1, 2020 (See
Appendix J). This EBP project posed minimal harm to potential participants and was not
considered a research study. Thus, an exempt review process application was completed by the
project leader and approved by the Valparaiso University IRB board on July 18, 2020 (See
Appendix K). The site facility Chief Nursing Officer (CNO) determined that this EBP project met
requirements for IRB exemption on August 20, 2020 (See Appendix L).
Participant anonymity was secured through the use of a numerical coding system (See
Appendix M). Each participant was given a confidential project identification number at the time
of project enrollment. This number was used in place of the participants’ names on the
demographic survey, pre- and post-intervention EHFScBS tool, and data collection excel
sheets. All communication between the participants and the project leader was kept confidential
and any information that could potentially identify a participant was omitted from data reports
and the EBP project publication. A handwritten hardcopy chart that included associated
participant identification numbers with participants names was kept in a locked drawer in the site
facilitator’s office (See Appendix N). Following completion of the project, this document was
destroyed.
Participation in the project was completely voluntary. Participants agreed to use the
MHA daily and approval was obtained for the project leader to call them each week to determine
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adherence to the intervention. A weekly follow up schedule was used to decrease the risk for
attrition (Song & Chung, 2010). Participants were notified that project participation could be
ceased at any time, for any reason, without consequence. Participants received no
compensation in exchange for participation.
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CHAPTER 4
FINDINGS
This EBP project was conducted to evaluate the effects of a participant-initiated MHA on
hospital readmission rates. The primary objective was to determine if the use of the application
was associated with a reduction in 30-day readmission rates. The PICOT question was: “In
adult Medicare beneficiaries who have a diagnosis of heart failure with recent hospitalization
(P), does the implementation of an interactive smartphone application (MHA), HFPath® (I),
compared to standard office protocol (C) decrease 30-day readmission rates (O) over an eightweek period (T)? Secondary objectives included evaluation of pre- and post-intervention
selfcare behaviors (EHFScBS), and overall participant satisfaction with the use of the
application. The project was implemented in a small, rural, for-profit hospital in Northwest
Indiana. This eight-week EBP project included the daily use of a MHA, HFPath ® by participants
who were recently discharged from the hospital following HF exacerbation. Participants were
asked to input physiologic data into the MHA daily. Following data input, the MHA generated a
color-coded zone that notified the user of exacerbation risk. Over the course of the project
timeline, the project leader called each participant weekly to determine intervention compliance
and to provide any needed assistance pertaining to use of the MHA. The desired outcome was
to establish a relationship between the use of the MHA and a reduction in hospital readmission.
A prospective between group comparison design allowed for assessment of thirty-day and 8week readmission rates for each group. SPSS 25 was used to perform a one-way multivariate
analysis of variance (MANOVA) to determine the effect of MHA use on hospital readmission. To
further assess if any association existed between the use of the MHA and readmission rates,
epidemiologic measures of association were evaluated. Organizational readmission rate data
were also evaluated pre- and post-intervention (See figure 4.2). Two secondary outcome
measures were analyzed in this EBP project. A paired samples t-test was calculated to compare
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pre- and post-intervention EHFScBS scores. Finally, a single sample t-test was conducted to
evaluate participants’ overall satisfaction with the project.
Participants
Project participants consisted of adults with a recent inpatient admission for HF
exacerbation. HF admission data were obtained, and potential participants (N = 18) were
identified through an extensive chart review process. The project leader met with potential
participants prior to hospital discharge to determine willingness to participate in the project. Of
the 18 inpatients who met inclusion criteria, nine of them agreed to participate. Those who
declined participation (n = 9) were included in the project as the comparison group (See Figure
4.1). One member of the intervention group was lost to attrition, data provided by this individual
were excluded from statistical analysis. Data were evaluated for eight intervention group
members.
Differences in demographic characteristics between groups were examined. The
intervention group was comprised of eight participants, six males and two females, with a mean
age of 58 years (sd = 15.57, range = 31-78). The comparison group was comprised of nine
participants, six males and three females, with a mean age of 68 years (sd = 14.11, range = 3888). No statistically significant differences were appreciated between groups when comparing
age, sex, race, ethnicity, and level of education. All (N = 17) individuals were NYHA class IV,
indicating advanced disease. A summary of demographic data is provided in Table 4.1.
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Participant recruitment flowchart
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Table 4.1
Characteristics of participants and non-participants

Characteristic of intervention Characteristic of comp group
group
n
%
n
%
Age (in years)
30-39
40-49
50-59
60-69
70+
Sex
Male
Female
Race
Caucasian
African American

Ethnicity
Hispanic/Latino
Non-Hispanic
Education
HS non-grad
HS grad
Some College
NYHA
Classification
I
II
III
IV

Statistical analysis
Pearson ChiSquare

p

2
0
1
3
2

25%
-12.5%
37.5
25%

1
0
0
4
4

11.1%
--44.4%
44.4%

3.143

.370

6
2

75%
25%

6
3

66.7%
33.3%

0.00

1.0

7
1

87.5%
12.5%

6
3

66.7%
33.3%

1.29

.257

0
7

-100%

1
8

11.1%
88.9%

1.059

.303

2
5
1

25%
62.5%
12.5%

5
4
--

55.6%
44.4%
--

2.686

.261

----8

----100%

----9

----100%

--

--
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Changes in Outcomes
The primary objective of this EBP project was to determine if the use of the MHA was
associated with a reduction in hospital readmission rates at 30-days and 8-weeks post
discharge. To further assess if any association existed between the use of the MHA and
readmission rates, epidemiologic measures of association were evaluated. Secondary
objectives included evaluation of pre- and post-intervention selfcare behaviors (EHFScBS), and
overall participant satisfaction with the use of the application.
Statistical Testing and Significance
This EBP project was designed as a prospective between group comparison, which
allowed for assessment of thirty-day and 8-week readmission rates for each group. Because the
project involved an intervention and a comparison group, with manipulation of the independent
variable (MHA use) and evaluation of readmissions at two different points in time (multiple
dependent variables), a one-way multivariate analysis of variance (MANOVA) was conducted to
test the primary project outcome.
The EBP project model evaluated the use of an intervention as it related to reduction in
readmission. Because the primary outcome of the project was to establish or evaluate an
association between MHA use and hospital admission, the project design resembled an
epidemiologic prospective cohort study. Cohort studies are observational studies, that can
involve manipulation of the independent variable depending on the phenomena being evaluated
(Song & Chung, 2010). Participants are identified at the beginning of the investigation as being
exposed to the independent variable (intervention group), or not (comparison group). Following
initial evaluation, participants are evaluated over an extended period of time to determine if a
causal effect exists between the variables. This EBP project closely replicated a cohort study,
however, due to the time restriction imposed by the university school calendar, the longitudinal
evaluation of dependent variables occurred over a much shorter period of time (8-weeks). To
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further evaluate if any association existed between the use of the MHA and readmission rates,
epidemiologic measures of association were evaluated.
Two secondary outcome measures were analyzed in this EBP project. A paired samples
t-test was calculated to compare pre- and post-intervention EHFScBS scores. Finally, a single
sample t-test was conducted to evaluate participants’ overall satisfaction with the project.
Findings
Primary Outcome. A one-way MANOVA was calculated to examine the effect of MHA
use on 30-day and 8-week post discharge readmission rates. No significant effect was found
(Llambda(2,4) = .804, p > 0.05). Neither 30-day or 8-weeks post intervention readmission rates
were significantly influenced by MHA use.
Epidemiologic Measures of Association. To further evaluate the presence of an
association between the use of the MHA and readmission rates, epidemiologic measures of
association were analyzed. Among participants in the intervention group (n = 8), one was
readmitted during the 30-day time period, and one additional participant was readmitted within
the 8-week period. Four members of the comparison group were readmitted within the 30-day
period, and one was readmitted within the 8-week period. Members of the comparison group
experienced more readmissions within the 30-day time period than the members of the
intervention group (OR = 0.156, 95% CI 0.013 - 1.828, p > 0.05, ARR = 0.33; NNT = 3). The
odds ratio less than 1.0 indicates that there was a potential protective effect secondary to the
use of the MHA. Those who used the MHA experienced 30-day readmission less than the
comparison group. However, because the 95% confidence interval spans 1.0, the decrease in
odds of being readmitted to the hospital secondary to use of the MHA did not reach statistical
significance.
Organizational Readmission Rates. HF-related readmission rate data were collected
pre- and post-intervention, dating back to September 2020, at project commencement. This
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EBP project did not decrease rates of readmission within the organization. In fact, readmission
rates peaked during the intervention period in November and December 2020 (See Figure 4.2).
Secondary Outcomes. Two secondary outcome measures were analyzed in this EBP
project. A paired samples t-test was calculated to compare pre- and post-intervention EHFScBS
scores. Finally, a single sample t-test was conducted to evaluate participants’ overall
satisfaction with the project.
The mean EHFScBS score was calculated for the intervention group immediately prior to
the intervention and following project completion. A paired samples t-test was calculated to
compare the mean pre-intervention EHFScBS score to the mean post-intervention EHFScBS
score. The preintervention mean was 3.81 (sd = .654), and the post-intervention mean was 2.57
(sd = .672) A statistically significant increase (See Figure 4.3) in participation in self-care
measures was observed (t(7) = 4.058, p = 0.005).
Finally, eight participants who completed the project requirements completed a
participant satisfaction survey. A single sample t-test that compared the mean participant
satisfaction score of the intervention group to a constant of zero was conducted. A significant
difference was found (t(7) = 7.79, p < 0.05). The mean satisfaction score of 1.63 (sd = .589) was
significantly different from the constant of zero, indicating a high degree of participant
satisfaction.
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Figure 4.2
Organizational Readmission Rates
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Figure 4.3
EHFScBS mean scores

Mean EHFScBS Score

4
3.5
3
2.5
2
1.5
1
0.5
0
Pre-Intervention

Post-Intervention

Pre-intervention M = 3.81 (sd = .654)
Post-intervention M = 2.57 (sd = .672)
(t(7) = 4.058, p = 0.005)
** Lower numbers are associated with increased participation in self-care behaviors. The
lower value post-intervention indicates an improvement.
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CHAPTER 5
DISCUSSION
Literature provides moderate support for the use of mobile technology to increase
participant self-care measures and decrease readmission rates. Multiple technological
modalities have been evaluated, including structured telephone support (Clark, 2018; Inglis et
al., 2015; Kotb et al., 2015; Lin et al., 2017; Aronow & Shamliyan, 2018), noninvasive remote
telemonitoring (Flogren et al., 2015; Lin et al., 2017; Clark, 2018; Bashi et al., 2017; Kitsiou,
Parre & Janna, 2015; Hamilton et al., 2018; Rosen et al., 2017l Frederix et al., 2019; Dadosky et
al., 2018), and implantable telemonitoring. This EBP project was conducted to evaluate the
impact of using a noninvasive, participant-initiated MHA on hospital readmission rates. The
project was implemented in a small, rural, for-profit hospital in Northwest Indiana, following
substantial Medicare reimbursement reductions due to high rates of readmission. The primary
objective was to determine if the use of the MHA was associated with a reduction in 30-day
readmission rates. The desired primary outcome was to establish a relationship between the
use of the MHA and a reduction in hospital readmission following initial hospitalization with HF
exacerbation. Secondary outcomes of interest included pre- and post-intervention scores on a
self-care screening tool, the EHFScBS (Jaarsma, 1999) and participant satisfaction with the
intervention. This final chapter of the EBP report will provide a thorough explanation of project
outcomes and compare those outcomes with findings from previous studies. This chapter will
also evaluate benefits of the use of the EBP framework, the Iowa Model Revised; discuss
strengths and limitations of the project; and offer implications for future HF-related mobile
technology research.
Explanation of Findings
The PICOT question for this EBP project was: “In adult Medicare beneficiaries who have
a diagnosis of heart failure with recent hospitalization (P), does the use of an interactive
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smartphone application (MHA), HFPath® (I), compared to standard office protocol (C) decrease
30-day readmission rates (O) over an eight-week period (T)? To evaluate this question,
individual and organizational readmission rates were reviewed at 30-days and 8-weeks post
intervention. Secondary outcomes of interest that included EHFScBS scores and participant
satisfaction scores were also evaluated for members of the intervention group.
Readmission Rates
To determine if MHA use had any influence on hospital readmission rates at 30 days
and eight weeks, a one-way MANOVA was calculated. No significant effect was found
(Llambda(2,4) = .804, p > .05). Neither 30-day nor eight-week post-intervention readmission
rates were significantly influenced by MHA use. Organizational readmission rates increased
over the course of the intervention period.
This EBP project closely resembled a short-term epidemiologic prospective cohort study;
thus epidemiologic measures of association were evaluated. More members of the comparison
group were readmitted within 30-days than members of the intervention group. However, the
odds ratio (OR = 0.156, 95% CI 0.013-1.828, p > 0.05, ARR = 0.33) did not reach statistical
significance.
The lack of statistically significant results was, to a certain degree, expected due to the
small sample size and relatively brief intervention period. Favorable outcomes were identified
through a comprehensive literature search of MHA use by patients who have HF; however,
studies with statistically significant results were much larger and occurred over extended
periods of time. Although statistically significant results were not achieved for the primary
outcome, clinical significance can be appreciated. Within this project population, participants in
the intervention group were readmitted less than members of the comparison group. The
prevention of one readmission has the potential to save the organization between $11,000
(Fitch et al, 2017) and $14,000 (Kilgore, Patel, Keilhorn, Maya, & Sharma, 2017). Thus, any
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reduction in readmission, although not statistically significant, can be considered financially
significant.
Outcomes of this EBP project are similar to those obtained in the systematic review (SR)
conducted by Long, Babbit, and Cohn (2017). Within this small-scale SR, members of the
intervention groups experienced less frequent readmission than comparison group members
and retrospective historical participants. However, smaller sample sizes and heterogeneity
amongst telemonitoring interventions failed to result in statistically significant reductions in 30day readmissions. Likewise, Dadosky et al., (2017) conducted a prospective, nonrandomized
trial to evaluate the effect of telemanagement of HF patients on 30-day readmission rates. This
study also had a small sample size that included 46 intervention group members and 96
historical patients. Members of the intervention group experienced a 27.24% relative risk
reduction despite having higher predicted readmission risk. A large difference between this
study and this EBP project was the location of the intervention group members. In the study
conducted by Dadosky et al., (2017), all members of the intervention group resided in the same
skilled nursing facility. Thus, care was provided to members of the intervention group by
healthcare personnel based on the results of telemonitoring interventions, allowing for prompt
reactions that resulted in reduced 30-day readmission rates. This EBP project failed to achieve
statistically significant results, however, if larger sample sizes or extended periods of time were
allowed, more favorable outcomes may have been achieved.
Heart Failure Self-care Measures
Heart failure is a chronic, progressive, debilitating disease that requires daily
management and frequent intervention to prevent overwhelming exacerbation of symptoms.
Variations in physiologic data can be easily assessed by patients in the home setting and
communicated to providers through the use of MHA platforms (Gorodeski et al., 2020; Werhahn,
Dathe, Rottmann, Franke, Vahdat, Hasenful, & Seidler, 2019; Athilingam, Labrador, Remo,
Mack, San Juan, & Elliott, 2016; Foster, 2018; Cajita, Hodgson, & Budhathoki, 2017).
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Participant self-care behaviors were evaluated with the EHFScBS (Jaarsma, 1999) prior to
intervention implementation and again following the eight-week intervention period. The
EHFScBS evaluated participant reported self-care activities on a five-point Likert scale. The
mean EHFScBS score was calculated immediately prior to and following the intervention. Mean
scores were compared using a paired sample t-test. A statistically significant increase in selfreported participation in self-care measures was observed (t(7) = .4058, p = 0.0005).This
outcome was not specifically reported within the literature. However, the reported increase in
participation in self-care measures is significant because participant evaluation of physiologic
data can lead to earlier recognition of exacerbation (AHA, 2017) and potential prevention of
hospital readmission through earlier intervention (Gorodeski et al., 2020). As described by
Pekmezaris et al., (2018), participant adherence to MHA use is time dependent. Maintaining
participant involvement in the MHA intervention is vital to project success. Thus, this EBP
project may have experienced improved participant self-care scores due to the relatively short
intervention period.
Participant Satisfaction
Following completion of the intervention period, eight participants completed a
participant satisfaction survey. The survey included six questions regarding the ease of MHA
download and daily usage. Responses to the questions were rated on a one-through-five scale,
with lower numbers corresponding to positive answers (i.e., strongly agree and agree). The
mean satisfaction score of 1.63 (sd = .589) was significantly different from the constant of zero,
indicating a high degree of participant satisfaction. It is important to evaluate participant
satisfaction because if not satisfied with the use of the MHA, participant adherence to the
intervention would decline (Pekmezaris et al., 2018). Overall, the use of the MHA was highly
regarded and during the project completion telephone conversation, many participants
expressed a desire to continue use of the application.
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In summary, this EBP project did not yield statistically significant results for the primary
outcomes. Specifically, MHA use did not appear to have any effect on 30-day or 8-week
readmission rates. Although statistical significance was not achieved, clinical significance can
be appreciated because even one prevented readmission has the potential to save the
organization a substantial amount of money. Positive, statistically significant outcomes were
appreciated for secondary outcomes, including participant involvement in self-care measures
and overall project satisfaction. Participants who completed the participant satisfaction survey
following the eight-week intervention period conveyed a desire to continue the MHA use.
Strengths and Limitations of the DNP Project
Strengths
This EBP project had many strengths. The MHA, HFPath® is an application that was
developed based on HF guidelines produced by the AHA, a well-known and highly respected
authority on cardiovascular care and research. The MHA had many strengths including, the
overall design, the ease of use, and the cost-effectiveness. First, the design of the application
included a virtual platform which allowed for project continuation even amidst quarantine
requirements and social distancing limitations imposed by COVID-19 restrictions. The project
design and virtual nature of the intervention did not require face-to-face interaction between the
project leader and the participants. Thus, there were no substantial delays created by the
inability to meet face-to-face with participants over the course of the project. Participants were
also able to continue use of the application amidst stay-at-home orders and quarantine
requirements. Secondly, the MHA was easy to download and easy to use. A simple participant
information packet was provided by the project leader that included a step-by-step guide for
downloading and using the application. Participants reported a high level of satisfaction with the
application and reported no issues with application download or daily input of physiologic data.
Independent use of the application allowed for increased participation in self-care measures
without increasing demand on providers. The information was not uploaded to a provider or a
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central monitoring device that would have required review by the provider. The project success
was reliant on participant use of the application and consultation with the provider in the event
that a warning indicator was received. Furthermore, the MHA was free. The free download
allowed for a wide range of participant use without limitation due to cost. The MHA is a costeffective method for adding a self-care measure to a patient’s care plan. Project sustainability is
more likely because the additional monitoring platform is free of charge.
The transitional care team within the project facility was wonderfully accommodating.
The team included two full-time registered nurses who reach out, via telephone, to patients who
are deemed high-risk for readmission following inpatient discharge, regardless of admitting
diagnosis. They arrange outpatient services for these patients and help to identify community
services that would add to patient success in the outpatient setting. The team provided free
weight scales and battery powered blood pressure cuffs for all project participants who did not
have one of these items at project onset. This generous contribution allowed participants to
complete the project requirements with no cost to them and allowed for more potential
participants to be included in the EBP project. In total, the transitional care team provided 4
weight scales and 5 battery powered blood pressure cuffs. These items were given to
participants prior to hospital discharge so that required materials were available to the
participant at the commencement of the project.
EBP Model
The use of the Iowa Model Revised was beneficial throughout the entirety of the project,
including project development, implementation, and evaluation phases. This EBP model has
undergone many revisions since inception and is ultimately designed to transition research
findings to clinical practice (Titler et al., 2001). The model was easy to use, as it provided an
outline for project development, implementation, data collection and outcome interpretation.
Practitioners who question current practice methods are encouraged to utilize this EBP model to
identify and evaluate methods that can potentially improve patient experience and/or outcomes.
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The Iowa Model Revised was chosen to guide this EBP project because of the high degree of
model adaptability and the allowance for revisions throughout the course of the project. The
seven sequential steps of the model were easy to use and followed a logical progression. The
use of the model allowed for project revisions to be made seamlessly throughout the project
timeline, despite unanticipated limitations imposed by COVID-19 restrictions. Ultimately, the
model facilitated nearly seamless progression through the phases of the project without any
limitations of the model’s use identified. If this project were to be completed again, the Iowa
Model Revised would remain a valid EBP model to follow for project development,
implementation, and evaluation.
Limitations
There were several project limitations identified. The COVID-19 pandemic created many
unique obstacles that initially delayed project implementation. Hospital visitation restrictions and
cancellation of student clinical experiences made it difficult to initially secure a project location. I
originally desired a partnership with an outpatient cardiology office, however, due to contracting
limitations imposed by COVID-19, I had to identify other potential sites. Even after securing a
project location, I was unable to begin completing clinical requirements until late in summer
2020. Additionally, once allowed to visit the project location, I was further restricted in my ability
to meet with and thus recruit project participants.
Another major limitation of this project was the small number of participants (n = 8)
willing to complete the intervention. There were many factors that contributed to the small
sample size. First, although the transitional care team and heart failure liaison within the
organization were excited about the project, none of them had time to specifically devote to the
recruitment process. The project leader and the site facilitator were the only ones who were able
to devote time to participant recruitment. Due to the overall reduction in access to patients, only
a small sample of patients were able to be introduced to the EBP project. Additionally, one
member of the intervention group was lost to attrition. Although one participant may not seem
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like a huge loss, with sample sizes this small, loss of even one participant was substantial.
Secondly, there was a lack of referral to the project from outpatient providers. I created an
informational packet that detailed the EBP project and distributed them to five outpatient
cardiology offices. This was done in effort to expand the pool of potential participants. However,
zero patients were referred. The reason for this is unknown. Lastly, the lack of smart device
ownership created a significant hindrance to project participation. Following worldwide
assimilation of smart device technology, I was not anticipating this limitation. However, it was
identified as the most frequent reason that patients declined project participation.
This EBP project consisted of participants who were all identified as NYHA category IV,
or end-stage HF. This was likely due to the fact that participants were recruited within the
inpatient setting. In order to meet inclusion criteria, participants had to have an initial inpatient
admission with a diagnosis of HF exacerbation; otherwise, it would not have been practical to
track time-based readmission rates. The progressive nature of HF and the relentless cyclical
nature of symptom exacerbation often leads to overwhelming symptoms, especially in advanced
stages, thus requiring readmission. Hospital readmission may have been a result of NYHA
classification, inclusion of only participants with end-stage disease, could have increased the
likelihood of insignificant primary outcome results.
Finally, outcomes of this EBP project were largely dependent on participant selfreporting of data. Each week, participants reported compliance with project recommendations,
such as daily input of data and follow-up communication with providers, if advised. Because the
data were not uploaded to a provider or a central monitoring station, the project leader was not
able to verify participant compliance. Also, the results of the EHFScBS tool were self-reported
subjective measures. Thus, participants could over- or underestimate responses to scale
prompts. If this project were to be repeated, a process for verifying participant use of the
application should be included.
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Overall, despite the limitations identified, the benefits of the EBP project outweighed any
risk of using the application. The addition of MHA use to standard care practices increased the
opportunity for participant self-care measures, and there were no negative outcomes related to
the use of the application identified. Overall, participants expressed a high level of satisfaction
with the project, therefore, the use of the MHA can continue to be included as a cost-effective
option for increasing self-care interventions in HF management. Unfortunately, 30-day and 8week readmission rates were not decreased to a level of statistical significance; however, the
benefits of MHA use can be referenced to justify continued use in practice.
Implications for the Future
This EBP project evaluated the effect(s) of the use of a HF self-care MHA on hospital
readmission rates and participant contribution to HF self-care management. Although the
intervention did not decrease 30-day or 8-week readmission rates to a level of statistical
significance, participation in self-care measures increased and a high-level of MHA satisfaction
was appreciated. Further implications for practice, EBP model, research, and education will be
discussed further within this section. Ideally, these implications can be used to guide further
research opportunities and practice and policy development to decrease HF-related
readmissions.
Practice
The use of the HFPath® and other MHA platforms that encourage participation in selfcare measures could be used in the future to effectively reduce hospital readmission rates.
Recent literature supports the continued evaluation of telehealth modalities for the management
of HF and other chronic conditions (Orso et al., 2020). In recent years, the project facility has
experienced higher than expected rates of hospital readmission. In fact, in 2018, the
organization was fined a large portion of Medicare reimbursement fees (Russell, 2018),
resulting in one of the highest fines in the state of Indiana. Due to the negative financial impact,
the organization has experimented various practices to reduce readmission rates. At the onset
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of this EBP project, the organization had a pre-established HF clinic within the hospital for
outpatient needs. However, this clinic was staffed by one nurse practitioner who quickly became
overwhelmed due to the increased demand for the clinic’s services. Readmission rate
reductions were not appreciated in significant amounts following the opening of the HF clinic.
Thus, the organization was desperate to identify further practices that could decrease reliance
on inpatient admissions.
Traditional models of healthcare provision involve interventions that are paternalistic and
provider-focused. Patients can experience lengthy delays in care due to factors related to the
provider, such as: Broken communication chains, busy schedules, and prior obligations. Patientcentered models of care are the gold standard of care delivery models in the post-ACA
healthcare system. The use of the MHA in this EBP project put the participant in the center of
the care delivery system. Participants became active members of the healthcare team; thus,
outcomes were heavily dependent upon patient compliance with project recommendations.
Further practice and policy development should be based upon facility needs, resources, and
patient preferences. The use of HFPath® can be seamlessly added to any therapy regimen
without increasing provider burden or imposing excessive responsibility on the patients’ part.
EBP Model
The Iowa Model Revised: Evidence-Based Practice to Promote Excellence in Health
Care was used as a framework to guide this EBP project. This model was chosen because it
involves a team-based approach to transition evidence to the patient level and impact change
within the healthcare setting. Also, the model is comprised of seven easy-to-follow steps that
allowed for an organized, sequential progression of the project objectives. Adaptability and
allowance for plan revisions were identified as further benefits of this model. The use of the
model encouraged the evaluation of project strengths and limitations throughout the project
timeline. Although a specific nursing theory was not used to guide this EBP project, future MHAfocused EBP projects could benefit from the application of a nursing theory such as, Dorthea
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Orem’s Theory of Self-care, which encourages patient independence and focuses on the
performance of individuals in self-care measures (Goes, José Lopes, Oliveira, Fonseca, &
Marôco, 2020).
Research
Although this EBP project did not reduce hospital readmission rates to a level of
statistical significance, it can be used to support further evaluation of MHA use and telehealth
modalities. Further well-designed, large-scale studies should be conducted to determine the
impact MHA use can have on readmission rates, evaluate long-term effects of MHA use, and
determine financial implications of MHA interventions on HF-related readmissions. Heart failure
is a complicated condition that may require a treatment plan that is equally as complex as the
condition itself. No single intervention is capable of completely preventing HF exacerbation and
subsequent hospital readmission; it is likely that multiple interventions may be necessary to
adequately reduce hospital readmission rates. Thus, the use of MHA platforms should be
evaluated in combination with other HF interventions.
Education
Patient knowledge deficit has been cited in most recent evidence findings as a reason
that patients do not participate in self-care measures of HF management (Ding et al., 2020).
Heart failure is a complex condition that providers struggle to understand; therefore, it is not
appropriate to assume that patients inherently know how to assess and manage disease
symptoms. Heart failure management involves daily assessment of physiologic symptoms, such
as vital signs and additional signs of deterioration. Education provided by HF experts is vital to
ensure patient understanding of the daily maintenance regimen and adherence to the treatment
plan (Allida et al., 2020). When patients understand the reason behind daily physiologic data
and symptom monitoring, compliance with self-care measures increases (Ding et al., 2020).
Further educational objectives should be designed to ensure patient understanding of the
condition and daily disease management regimens.
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Participant education was provided prior to intervention implementation. All members of
the intervention group were provided with a folder (Appendix O) that included detailed
information about self-care management and MHA use, in addition to face-to-face education
provided by the project leader. Additionally, providers including cardiologists, the HF liaison, and
the APRN at the HF clinic were presented with education about the EBP project prior to
commencement. No objections or proposed revisions to the project plan were elicited.
Continued education was provided during weekly telephone follow-ups with participants and
care takers. Participants reported satisfaction with the amount of individualized education
provided throughout the EBP project.
Conclusion
In conclusion, this EBP project was implemented to determine the effect of using a HF
specific MHA that incorporated participant contribution to a self-care management regimen.
Although the primary outcome of reduced hospital readmission rates did not reach statistical
significance, clinical significance can be appreciated, as participants in the intervention group
were readmitted less than those in the comparison group. This finding indicates that the use of
the free MHA, as an adjunctive method of HF maintenance in a pre-established treatment plan
can be of clinical and financial significance. The secondary outcome, which included participant
self-reporting of participation in self-care measures, as evaluated with the EHFScBS tool,
indicated improved contribution to self-care maintenance by the intervention group, following
EBP project completion. Participants also reported high levels of satisfaction with the use of the
MHA. These findings are promising, indicating that HF management can be enhanced by this
patient-driven, cost-effective, and sustainable method of disease maintenance.
This EBP project has provided support for the use of MHA platforms in the management
of chronic disease, specifically heart failure. This EBP project was designed to answer the
PICOT question, “In adult Medicare beneficiaries who have a diagnosis of heart failure with
recent hospitalization (P), does the implementation of an interactive smartphone application,
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HFPath® (I), compared to standard office protocol (C) decrease 30-day readmission rates (O)
over an eight-week period (T)? The mixed project outcomes were consistent with those reported
in the literature, owing in part to the complex nature of the condition. No single intervention has
been effective at substantially reducing HF readmission rates (Orso et al., 2020); however, MHA
use can be seamlessly added to current treatment plans to increase participant self-care,
without adding any burden to providers or organizations. Reduction of hospital readmission
rates will continue to be a primary focus of healthcare organizations, secondary to financial
incentives imposed by Medicare. This EBP project is one of many efforts designed to identify
and evaluate interventions aimed at reducing readmission rates. Outcomes from this EBP
project can be used to guide future EBP projects and research on MHA use in HF management.
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Appendix D
Provider Information for Outpatient Recruitment

“A Smartphone Intervention to Reduce Hospital Readmission Rates in Adult Patients who have
Heart Failure”
Purpose: This is an evidence-based practice project. The goal of the project is to increase patient self-care measures,
recognize symptoms of exacerbation early, and allow for the opportunity to intervene prior to the need for
hospitalization and aggressive treatment. The desired outcome of the project is reduction in heart failure-related 30day readmission rates.
Project Inclusion criteria: Participants must be 18 years of age or older, have a diagnosis of heart failure
(regardless of NYHA stage), have a recent hospital admission with diagnosis of heart failure exacerbation, and have
access to a smart device, such as a smart phone, tablet, laptop, or desktop computer. Pregnant women and children
are not eligible for participation.
Intervention: HFPath® is a smartphone application that was produced by The American Heart Association.
HFPath® will be used for this EBP project to encourage patient self-care measures, increase communication
between patient and provider, allow for early intervention during symptom exacerbation, and ultimately decrease
30-day readmission rates.

Program Overview
Inpatient heart failure patients will be provided with education about the project prior to discharge. The project
leader will be responsible for assisting patients to download the application and providing introductory
education about the application.
The patient will be given the project leader’s contact information. Participants will be able to call the project
leader at any time for assistance troubleshooting questions about the application.
After discharge, the participants will input weight, blood pressure, and symptoms daily into the areas prompted
by the smartphone application. Based on preset criteria, the application will generate a “heart failure zone”
color. Green equates to “all clear,” yellow signifies “caution,” and red indicates “emergency.”
Patients are encouraged to call the provider (previously established cardiologist or The Heart and Vascular
center at ***** hospital) if the application instructs them to do so (after receiving yellow or red notifications).
The project leader will contact participants weekly throughout the 8-week project to determine usability and
assist with any complications encountered.
Participants will be encouraged to use the application daily (approximately 10 minutes per day) for a minimum
of 8 weeks. After 8 weeks, 30-day readmission data and Heart Failure self-care measures data will be
reevaluated.
Participants may choose to halt participation at any time for any reason during the 8-week period. This program
is offered at no cost to the patient, provider, or institution. There will be no extra office visits required.

Project Leader: Jami Crisman, BSN, RN
jami.crisman@valpo.edu or 317-340-8741 (Cell)
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Permission to use the EHFScBS
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Appendix H
Project Timeline
Pre-intervention Data Collection
June 2020 – September 2020
Participant Recruitment/Education –
Dates will vary for all participants
** Final participant to be enrolled by 11/1/2020

Organizational HF-specific 30-day readmission rates
Prior to inpatient discharge:
Program introduction
Mobile Phone Application Education
Post discharge telephone meeting:
Individual HF admission history
Participant demographic survey
EHFScBS (Pre)
Application education provided by project leader

Telephone Follow-up
Week 1

Ensure successful download of application. Assess
adherence based on participant self-report.

Week 2

Assess adherence based on participant self-report.
Evaluate participant admission data.

Week 3

Assess adherence based on participant self-report.
Evaluate participant admission data.

Week 4

Assess adherence based on participant self-report.
Evaluate participant admission data.

Week 5

Assess adherence based on participant self-report.
Evaluate participant admission data.

Week 6

Assess adherence based on participant self-report.
Evaluate participant admission data.

Week 7

Assess adherence based on participant self-report.
Evaluate participant admission data.

Week 8
Project completion
Dates will vary for all participants
Final intervention period will be completed by
12/27/2020
Follow-up telephone meetings will be completed
prior to 12/31/2020
Final data collection/evaluation/analysis
Completed by January 17, 2021

Post-intervention telephone meeting:
Patient satisfaction survey
EHFScBS (Post)
Review Individual 30-day readmission rates (Post)
Statistical analysis

Organizational post-intervention HF-related 30-day
readmission rates
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Appendix J
Collaborative Institutional Training Initiative (CITI) completion certificate
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Appendix N
Participant Coding System Hardcopy
Participant #

Admit
Date

D/C Date

Admit
Date

D/C Date

Weekly Follow-Up

Readmissions
w/in 30-days
w/in 8 weeks

1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
Comparison #
10.0
11.0
12.0
13.0
14.0
15.0
16.0
17.0
18.0

Readmissions
w/in 30-days
w/in 8-weeks
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Appendix O
Participant information folder

*Logo eliminated from project information documents in compliance with AHA (2020) contract
agreement

